Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Lung Cancer

  Free Subscription


Articles published in PLoS One

Retrieve available abstracts of 450 articles:
HTML format
Text format



Single Articles


    January 2018
  1. CHEN WC, Su VY, Yu WK, Chen YW, et al
    Prognostic factors of noninvasive mechanical ventilation in lung cancer patients with acute respiratory failure.
    PLoS One. 2018;13:e0191204.
    PubMed     Text format     Abstract available



  2. Correction: Risk of thromboembolism in cisplatin versus carboplatin-treated patients with lung cancer.
    PLoS One. 2018;13:e0191454.
    PubMed     Text format     Abstract available


  3. CHUANG MC, Yang YH, Tsai YH, Hsieh MJ, et al
    Survival benefit associated with metformin use in inoperable non-small cell lung cancer patients with diabetes: A population-based retrospective cohort study.
    PLoS One. 2018;13:e0191129.
    PubMed     Text format     Abstract available


  4. BELQAID K, Tishelman C, Orrevall Y, Mansson-Brahme E, et al
    Dealing with taste and smell alterations-A qualitative interview study of people treated for lung cancer.
    PLoS One. 2018;13:e0191117.
    PubMed     Text format     Abstract available


  5. PARK S, Ha S, Lee SH, Paeng JC, et al
    Intratumoral heterogeneity characterized by pretreatment PET in non-small cell lung cancer patients predicts progression-free survival on EGFR tyrosine kinase inhibitor.
    PLoS One. 2018;13:e0189766.
    PubMed     Text format     Abstract available


  6. SHIN DW, Chun S, Kim YI, Kim SJ, et al
    A national survey of lung cancer specialists' views on low-dose CT screening for lung cancer in Korea.
    PLoS One. 2018;13:e0192626.
    PubMed     Text format     Abstract available


  7. KILVAER TK, Rakaee M, Hellevik T, Ostman A, et al
    Tissue analyses reveal a potential immune-adjuvant function of FAP-1 positive fibroblasts in non-small cell lung cancer.
    PLoS One. 2018;13:e0192157.
    PubMed     Text format     Abstract available


  8. KIRIU T, Yamamoto M, Nagano T, Hazama D, et al
    The time-series behavior of neutrophil-to-lymphocyte ratio is useful as a predictive marker in non-small cell lung cancer.
    PLoS One. 2018;13:e0193018.
    PubMed     Text format     Abstract available


  9. HOVANEC J, Siemiatycki J, Conway DI, Olsson A, et al
    Lung cancer and socioeconomic status in a pooled analysis of case-control studies.
    PLoS One. 2018;13:e0192999.
    PubMed     Text format     Abstract available


  10. PAK K, Kim K, Kim MH, Eom JS, et al
    A decision tree model for predicting mediastinal lymph node metastasis in non-small cell lung cancer with F-18 FDG PET/CT.
    PLoS One. 2018;13:e0193403.
    PubMed     Text format     Abstract available


  11. TAMIYA M, Tamiya A, Inoue T, Kimura M, et al
    Metastatic site as a predictor of nivolumab efficacy in patients with advanced non-small cell lung cancer: A retrospective multicenter trial.
    PLoS One. 2018;13:e0192227.
    PubMed     Text format     Abstract available



  12. Correction: Modulation of Pathways Underlying Distinct Cell Death Mechanisms in Two Human Lung Cancer Cell Lines in Response to SN1 Methylating Agents Treatment.
    PLoS One. 2018;13:e0194257.
    PubMed     Text format     Abstract available


  13. CARVALHO S, Leijenaar RTH, Troost EGC, van Timmeren JE, et al
    18F-fluorodeoxyglucose positron-emission tomography (FDG-PET)-Radiomics of metastatic lymph nodes and primary tumor in non-small cell lung cancer (NSCLC) - A prospective externally validated study.
    PLoS One. 2018;13:e0192859.
    PubMed     Text format     Abstract available


  14. MALEKI VAREKI S, Salim KY, Danter WR, Koropatnick J, et al
    Novel anti-cancer drug COTI-2 synergizes with therapeutic agents and does not induce resistance or exhibit cross-resistance in human cancer cell lines.
    PLoS One. 2018;13:e0191766.
    PubMed     Text format     Abstract available


  15. HAN Y, Kim HJ, Kong KA, Kim SJ, et al
    Diagnosis of small pulmonary lesions by transbronchial lung biopsy with radial endobronchial ultrasound and virtual bronchoscopic navigation versus CT-guided transthoracic needle biopsy: A systematic review and meta-analysis.
    PLoS One. 2018;13:e0191590.
    PubMed     Text format     Abstract available


  16. ZHANG Z, Wang H, Ding Q, Xing Y, et al
    Establishment of patient-derived tumor spheroids for non-small cell lung cancer.
    PLoS One. 2018;13:e0194016.
    PubMed     Text format     Abstract available


  17. MIHOUB M, Pichette A, Sylla B, Gauthier C, et al
    Bidesmosidic betulin saponin bearing L-rhamnopyranoside moieties induces apoptosis and inhibition of lung cancer cells growth in vitro and in vivo.
    PLoS One. 2018;13:e0193386.
    PubMed     Text format     Abstract available


  18. BUHL IK, Santoni-Rugiu E, Ravn J, Hansen A, et al
    Molecular prediction of adjuvant cisplatin efficacy in Non-Small Cell Lung Cancer (NSCLC)-validation in two independent cohorts.
    PLoS One. 2018;13:e0194609.
    PubMed     Text format     Abstract available


  19. DEHUA Z, Mingming C, Jisheng W
    Meta-analysis of gemcitabine in brief versus prolonged low-dose infusion for advanced non-small cell lung cancer.
    PLoS One. 2018;13:e0193814.
    PubMed     Text format     Abstract available


  20. CHANG WY, Wu YL, Su PL, Yang SC, et al
    The impact of EGFR mutations on the incidence and survival of stages I to III NSCLC patients with subsequent brain metastasis.
    PLoS One. 2018;13:e0192161.
    PubMed     Text format     Abstract available


  21. KIM CR, Kim EY, Kim YS, Ahn HK, et al
    Histologic subtypes are not associated with the presence of sarcopenia in lung cancer.
    PLoS One. 2018;13:e0194626.
    PubMed     Text format     Abstract available


  22. CHEN CH, Chang CK, Tu CY, Liao WC, et al
    Radiomic features analysis in computed tomography images of lung nodule classification.
    PLoS One. 2018;13:e0192002.
    PubMed     Text format     Abstract available


  23. FU M, Travier N, Martin-Sanchez JC, Martinez-Sanchez JM, et al
    Identifying high-risk individuals for lung cancer screening: Going beyond NLST criteria.
    PLoS One. 2018;13:e0195441.
    PubMed     Text format     Abstract available


  24. LEE EH, Park CH, Choi HJ, Kawala RA, et al
    Dexamethasone modified by gamma-irradiation as a novel anticancer drug in human non-small cell lung cancer.
    PLoS One. 2018;13:e0194341.
    PubMed     Text format     Abstract available


  25. ERNST AK, Putscher A, Samatov TR, Suling A, et al
    Knockdown of L1CAM significantly reduces metastasis in a xenograft model of human melanoma: L1CAM is a potential target for anti-melanoma therapy.
    PLoS One. 2018;13:e0192525.
    PubMed     Text format     Abstract available


  26. LIU K, Zheng D, Xu G, Du Z, et al
    Correction: Local thoracic therapy improve prognosis for stage IV non-small cell lung cancer patients combined with chemotherapy: A Surveillance, Epidemiology, and End Results database analysis.
    PLoS One. 2018;13:e0196618.
    PubMed     Text format     Abstract available


  27. BISAGNI A, Pagano M, Maramotti S, Zanelli F, et al
    Higher expression of miR-133b is associated with better efficacy of erlotinib as the second or third line in non-small cell lung cancer patients.
    PLoS One. 2018;13:e0196350.
    PubMed     Text format     Abstract available


  28. CIRCU M, Cardelli J, Barr MP, O'Byrne K, et al
    Correction: Modulating lysosomal function through lysosome membrane permeabilization or autophagy suppression restores sensitivity to cisplatin in refractory non-small-cell lung cancer cells.
    PLoS One. 2018;13:e0197016.
    PubMed     Text format     Abstract available


  29. DEROUEN MC, Hu L, McKinley M, Gali K, et al
    Incidence of lung cancer histologic cell-types according to neighborhood factors: A population based study in California.
    PLoS One. 2018;13:e0197146.
    PubMed     Text format     Abstract available


  30. EDELSBERG J, Weycker D, Atwood M, Hamilton-Fairley G, et al
    Cost-effectiveness of an autoantibody test (EarlyCDT-Lung) as an aid to early diagnosis of lung cancer in patients with incidentally detected pulmonary nodules.
    PLoS One. 2018;13:e0197826.
    PubMed     Text format     Abstract available


  31. KIM H, Kwon HJ, Park SY, Park Y, et al
    Clinicopathological analysis and prognostic significance of programmed cell death-ligand 1 protein and mRNA expression in non-small cell lung cancer.
    PLoS One. 2018;13:e0198634.
    PubMed     Text format     Abstract available


  32. ZHANG X, Nakajima T, Kim M, Yamaguchi A, et al
    Activatable fluorescence detection of epidermal growth factor receptor positive mediastinal lymph nodes in murine lung cancer model.
    PLoS One. 2018;13:e0198224.
    PubMed     Text format     Abstract available


  33. WALTER RFH, Rozynek P, Casjens S, Werner R, et al
    Methylation of L1RE1, RARB, and RASSF1 function as possible biomarkers for the differential diagnosis of lung cancer.
    PLoS One. 2018;13:e0195716.
    PubMed     Text format     Abstract available


  34. KIM KI, Jun JH, Baek H, Kim JH, et al
    Oral administration of herbal medicines for radiation pneumonitis in lung cancer patients: A systematic review and meta-analysis.
    PLoS One. 2018;13:e0198015.
    PubMed     Text format     Abstract available


  35. GU L, Wang Z, Zuo J, Li H, et al
    Prognostic significance of NF-kappaB expression in non-small cell lung cancer: A meta-analysis.
    PLoS One. 2018;13:e0198223.
    PubMed     Text format     Abstract available


  36. CHORNER PM, Moorehead RA
    A-674563, a putative AKT1 inhibitor that also suppresses CDK2 activity, inhibits human NSCLC cell growth more effectively than the pan-AKT inhibitor, MK-2206.
    PLoS One. 2018;13:e0193344.
    PubMed     Text format     Abstract available


  37. SILVA MA, Ryall KA, Wilm C, Caldara J, et al
    PD-L1 immunostaining scoring for non-small cell lung cancer based on immunosurveillance parameters.
    PLoS One. 2018;13:e0196464.
    PubMed     Text format     Abstract available


    January 2017
  38. ZHANG Y, Xue Q, Pan G, Meng QH, et al
    Integrated Analysis of Genome-Wide Copy Number Alterations and Gene Expression Profiling of Lung Cancer in Xuanwei, China.
    PLoS One. 2017;12:e0169098.
    PubMed     Text format     Abstract available


  39. HUYNH E, Coroller TP, Narayan V, Agrawal V, et al
    Associations of Radiomic Data Extracted from Static and Respiratory-Gated CT Scans with Disease Recurrence in Lung Cancer Patients Treated with SBRT.
    PLoS One. 2017;12:e0169172.
    PubMed     Text format     Abstract available


  40. BEN-LULU S, Ziv T, Weisman-Shomer P, Benhar M, et al
    Nitrosothiol-Trapping-Based Proteomic Analysis of S-Nitrosylation in Human Lung Carcinoma Cells.
    PLoS One. 2017;12:e0169862.
    PubMed     Text format     Abstract available


  41. XIAO L, Liu N, Zhang G, Zhang H, et al
    Late-Course Adaptive Adjustment Based on Metabolic Tumor Volume Changes during Radiotherapy May Reduce Radiation Toxicity in Patients with Non-Small Cell Lung Cancer.
    PLoS One. 2017;12:e0170901.
    PubMed     Text format     Abstract available


  42. LOKK K, Vooder T, Kolde R, Valk K, et al
    Correction: Methylation Markers of Early-Stage Non-Small Cell Lung Cancer.
    PLoS One. 2017;12:e0170833.
    PubMed     Text format     Abstract available


  43. NATTENMULLER J, Wochner R, Muley T, Steins M, et al
    Prognostic Impact of CT-Quantified Muscle and Fat Distribution before and after First-Line-Chemotherapy in Lung Cancer Patients.
    PLoS One. 2017;12:e0169136.
    PubMed     Text format     Abstract available


  44. TAKASE Y, Usui K, Shimizu K, Kimura Y, et al
    Highly sensitive detection of a HER2 12-base pair duplicated insertion mutation in lung cancer using the Eprobe-PCR method.
    PLoS One. 2017;12:e0171225.
    PubMed     Text format     Abstract available


  45. HOU LK, Ma YS, Han Y, Lu GX, et al
    Association of microRNA-33a Molecular Signature with Non-Small Cell Lung Cancer Diagnosis and Prognosis after Chemotherapy.
    PLoS One. 2017;12:e0170431.
    PubMed     Text format     Abstract available


  46. WALKER R, Deppen S, Smith G, Shi C, et al
    68Ga-DOTATATE PET/CT imaging of indeterminate pulmonary nodules and lung cancer.
    PLoS One. 2017;12:e0171301.
    PubMed     Text format     Abstract available


  47. TSUCHIYA N, Doai M, Usuda K, Uramoto H, et al
    Non-small cell lung cancer: Whole-lesion histogram analysis of the apparent diffusion coefficient for assessment of tumor grade, lymphovascular invasion and pleural invasion.
    PLoS One. 2017;12:e0172433.
    PubMed     Text format     Abstract available


  48. AOKI N, Mochizuki K, Matsui Y
    DNA methylation of the Fthl17 5'-upstream region regulates differential Fthl17 expression in lung cancer cells and germline stem cells.
    PLoS One. 2017;12:e0172219.
    PubMed     Text format     Abstract available


  49. CHEN Y, Min L, Ren C, Xu X, et al
    miRNA-148a serves as a prognostic factor and suppresses migration and invasion through Wnt1 in non-small cell lung cancer.
    PLoS One. 2017;12:e0171751.
    PubMed     Text format     Abstract available


  50. SUDA K, Rozeboom L, Yu H, Ellison K, et al
    Potential effect of spliceosome inhibition in small cell lung cancer irrespective of the MYC status.
    PLoS One. 2017;12:e0172209.
    PubMed     Text format     Abstract available


  51. HRADILOVA N, Sadilkova L, Palata O, Mysikova D, et al
    Generation of dendritic cell-based vaccine using high hydrostatic pressure for non-small cell lung cancer immunotherapy.
    PLoS One. 2017;12:e0171539.
    PubMed     Text format     Abstract available


  52. SOK SP, Arshad NM, Azmi MN, Awang K, et al
    The apoptotic effect of 1'S-1'-Acetoxychavicol Acetate (ACA) enhanced by inhibition of non-canonical autophagy in human non-small cell lung cancer cells.
    PLoS One. 2017;12:e0171329.
    PubMed     Text format     Abstract available


  53. KAWAZOE H, Yano A, Ishida Y, Takechi K, et al
    Non-steroidal anti-inflammatory drugs induce severe hematologic toxicities in lung cancer patients receiving pemetrexed plus carboplatin: A retrospective cohort study.
    PLoS One. 2017;12:e0171066.
    PubMed     Text format     Abstract available


  54. HUNG MS, Chen IC, Lee CP, Huang RJ, et al
    Statin improves survival in patients with EGFR-TKI lung cancer: A nationwide population-based study.
    PLoS One. 2017;12:e0171137.
    PubMed     Text format     Abstract available


  55. JIAO DM, Yan L, Wang LS, Hu HZ, et al
    Exploration of inhibitory mechanisms of curcumin in lung cancer metastasis using a miRNA- transcription factor-target gene network.
    PLoS One. 2017;12:e0172470.
    PubMed     Text format     Abstract available


  56. NARITA M, Shimura E, Nagasawa A, Aiuchi T, et al
    Chronic treatment of non-small-cell lung cancer cells with gefitinib leads to an epigenetic loss of epithelial properties associated with reductions in microRNA-155 and -200c.
    PLoS One. 2017;12:e0172115.
    PubMed     Text format     Abstract available


  57. SHEN G, Lan Y, Zhang K, Ren P, et al
    Comparison of 18F-FDG PET/CT and DWI for detection of mediastinal nodal metastasis in non-small cell lung cancer: A meta-analysis.
    PLoS One. 2017;12:e0173104.
    PubMed     Text format     Abstract available


  58. HOU PF, Zhu LJ, Chen XY, Qiu ZQ, et al
    Age-related changes in CD4+CD25+FOXP3+ regulatory T cells and their relationship with lung cancer.
    PLoS One. 2017;12:e0173048.
    PubMed     Text format     Abstract available


  59. HORIBE R, Hirohashi Y, Asano T, Mariya T, et al
    Brother of the regulator of the imprinted site (BORIS) variant subfamily 6 is a novel target of lung cancer stem-like cell immunotherapy.
    PLoS One. 2017;12:e0171460.
    PubMed     Text format     Abstract available


  60. SHIN DW, Kim YI, Kim SJ, Kim JS, et al
    Lung cancer specialist physicians' attitudes towards e-cigarettes: A nationwide survey.
    PLoS One. 2017;12:e0172568.
    PubMed     Text format     Abstract available


  61. YIN J, Zhao J, Hu W, Yang G, et al
    Disturbance of the let-7/LIN28 double-negative feedback loop is associated with radio- and chemo-resistance in non-small cell lung cancer.
    PLoS One. 2017;12:e0172787.
    PubMed     Text format     Abstract available


  62. SHEEHAN DF, Criss SD, Gazelle GS, Pandharipande PV, et al
    Evaluating lung cancer screening in China: Implications for eligibility criteria design from a microsimulation modeling approach.
    PLoS One. 2017;12:e0173119.
    PubMed     Text format     Abstract available


  63. ROSENBERGER A, Sohns M, Friedrichs S, Hung RJ, et al
    Gene-set meta-analysis of lung cancer identifies pathway related to systemic lupus erythematosus.
    PLoS One. 2017;12:e0173339.
    PubMed     Text format     Abstract available


  64. YANG Y, Qiu S, Qian L, Tian Y, et al
    OCF can repress tumor metastasis by inhibiting epithelial-mesenchymal transition involved in PTEN/PI3K/AKT pathway in lung cancer cells.
    PLoS One. 2017;12:e0174021.
    PubMed     Text format     Abstract available


  65. RYUGE S, Sato Y, Nagashio R, Hiyoshi Y, et al
    Prognostic significance of nestin expression in patients with resected non-small cell lung cancer treated with platinum-based adjuvant chemotherapy; relationship between nestin expression and epithelial to mesenchymal transition related markers.
    PLoS One. 2017;12:e0173886.
    PubMed     Text format     Abstract available


  66. HOU GX, Liu P, Yang J, Wen S, et al
    Mining expression and prognosis of topoisomerase isoforms in non-small-cell lung cancer by using Oncomine and Kaplan-Meier plotter.
    PLoS One. 2017;12:e0174515.
    PubMed     Text format     Abstract available


  67. OGUMA T, Nagaoka T, Kurahashi M, Kobayashi N, et al
    Clinical contributions of exhaled volatile organic compounds in the diagnosis of lung cancer.
    PLoS One. 2017;12:e0174802.
    PubMed     Text format     Abstract available


  68. FAN L, Chen L, Ni X, Guo S, et al
    Genetic variant of miR-4293 rs12220909 is associated with susceptibility to non-small cell lung cancer in a Chinese Han population.
    PLoS One. 2017;12:e0175666.
    PubMed     Text format     Abstract available


  69. DAVIES J, Patel M, Gridelli C, de Marinis F, et al
    Real-world treatment patterns for patients receiving second-line and third-line treatment for advanced non-small cell lung cancer: A systematic review of recently published studies.
    PLoS One. 2017;12:e0175679.
    PubMed     Text format     Abstract available


  70. SHEN G, Lan Y, Zhang K, Ren P, et al
    Correction: Comparison of 18F-FDG PET/CT and DWI for detection of mediastinal nodal metastasis in non-small cell lung cancer: A meta-analysis.
    PLoS One. 2017;12:e0176150.
    PubMed     Text format     Abstract available


  71. HE M, Yang Z, Zhang L, Song C, et al
    Additive effects of cherlerythrine chloride combination with erlotinib in human non-small cell lung cancer cells.
    PLoS One. 2017;12:e0175466.
    PubMed     Text format     Abstract available


  72. SHIRAI K, Kawashima M, Saitoh JI, Abe T, et al
    Clinical outcomes using carbon-ion radiotherapy and dose-volume histogram comparison between carbon-ion radiotherapy and photon therapy for T2b-4N0M0 non-small cell lung cancer-A pilot study.
    PLoS One. 2017;12:e0175589.
    PubMed     Text format     Abstract available


  73. CAO G, Cheng D, Ye L, Pan Y, et al
    Surgical resection of pulmonary metastases from colorectal cancer: 11 years of experiences.
    PLoS One. 2017;12:e0175284.
    PubMed     Text format     Abstract available


  74. XU Z, Yan Y, Xiao L, Dai S, et al
    Radiosensitizing effect of diosmetin on radioresistant lung cancer cells via Akt signaling pathway.
    PLoS One. 2017;12:e0175977.
    PubMed     Text format     Abstract available


  75. INOUE Y, Shiihara J, Miyazawa H, Ohta H, et al
    A highly specific and sensitive massive parallel sequencer-based test for somatic mutations in non-small cell lung cancer.
    PLoS One. 2017;12:e0176525.
    PubMed     Text format     Abstract available


  76. FUKUDA T, Nomura M, Kato Y, Tojo H, et al
    A selected reaction monitoring mass spectrometric assessment of biomarker candidates diagnosing large-cell neuroendocrine lung carcinoma by the scaling method using endogenous references.
    PLoS One. 2017;12:e0176219.
    PubMed     Text format     Abstract available


  77. BAILEY G, Healy A, Young BD, Sharma E, et al
    Relative predictive value of lung cancer screening CT versus myocardial perfusion attenuation correction CT in the evaluation of coronary calcium.
    PLoS One. 2017;12:e0175678.
    PubMed     Text format     Abstract available


  78. TAKAMOCHI K, Mogushi K, Kawaji H, Imashimizu K, et al
    Correlation of EGFR or KRAS mutation status with 18F-FDG uptake on PET-CT scan in lung adenocarcinoma.
    PLoS One. 2017;12:e0175622.
    PubMed     Text format     Abstract available


  79. DENEKA AY, Haber L, Kopp MC, Gaponova AV, et al
    Tumor-targeted SN38 inhibits growth of early stage non-small cell lung cancer (NSCLC) in a KRas/p53 transgenic mouse model.
    PLoS One. 2017;12:e0176747.
    PubMed     Text format     Abstract available


  80. DURDA K, Kaklewski K, Gupta S, Szydlowski M, et al
    Serum folate concentration and the incidence of lung cancer.
    PLoS One. 2017;12:e0177441.
    PubMed     Text format     Abstract available


  81. KIM JS, Cho MS, Nam JH, Kim HJ, et al
    Prognostic impact of EGFR mutation in non-small-cell lung cancer patients with family history of lung cancer.
    PLoS One. 2017;12:e0177015.
    PubMed     Text format     Abstract available


  82. JUN HY, Kim TH, Choi JW, Lee YH, et al
    Evaluation of connectivity map-discovered celastrol as a radiosensitizing agent in a murine lung carcinoma model: Feasibility study of diffusion-weighted magnetic resonance imaging.
    PLoS One. 2017;12:e0178204.
    PubMed     Text format     Abstract available


  83. HOLMBOE S, Hansen PL, Thisgaard H, Block I, et al
    Evaluation of somatostatin and nucleolin receptors for therapeutic delivery in non-small cell lung cancer stem cells applying the somatostatin-analog DOTATATE and the nucleolin-targeting aptamer AS1411.
    PLoS One. 2017;12:e0178286.
    PubMed     Text format     Abstract available


  84. PARK SL, Murphy SE, Wilkens LR, Stram DO, et al
    Association of CYP2A6 activity with lung cancer incidence in smokers: The multiethnic cohort study.
    PLoS One. 2017;12:e0178435.
    PubMed     Text format     Abstract available


  85. CAMERON SJS, Lewis KE, Huws SA, Hegarty MJ, et al
    A pilot study using metagenomic sequencing of the sputum microbiome suggests potential bacterial biomarkers for lung cancer.
    PLoS One. 2017;12:e0177062.
    PubMed     Text format     Abstract available


  86. CHANG HW, Lin ZM, Wu MJ, Wang LY, et al
    Characterization of a transgenic mouse model exhibiting spontaneous lung adenocarcinomas with a metastatic phenotype.
    PLoS One. 2017;12:e0175586.
    PubMed     Text format     Abstract available


  87. CARRERAS-TORRES R, Johansson M, Haycock PC, Wade KH, et al
    Obesity, metabolic factors and risk of different histological types of lung cancer: A Mendelian randomization study.
    PLoS One. 2017;12:e0177875.
    PubMed     Text format     Abstract available


  88. CHANG YP, Chen YM, Lai CH, Lin CY, et al
    The impact of de novo liver metastasis on clinical outcome in patients with advanced non-small-cell lung cancer.
    PLoS One. 2017;12:e0178676.
    PubMed     Text format     Abstract available


  89. WEISS GJ, Byron SA, Aldrich J, Sangal A, et al
    A prospective pilot study of genome-wide exome and transcriptome profiling in patients with small cell lung cancer progressing after first-line therapy.
    PLoS One. 2017;12:e0179170.
    PubMed     Text format     Abstract available


  90. ABERNETHY AP, Arunachalam A, Burke T, McKay C, et al
    Real-world first-line treatment and overall survival in non-small cell lung cancer without known EGFR mutations or ALK rearrangements in US community oncology setting.
    PLoS One. 2017;12:e0178420.
    PubMed     Text format     Abstract available


  91. WU YT, Li X, Liu ZL, Xu Z, et al
    Hepatitis B virus reactivation and antiviral prophylaxis during lung cancer chemotherapy: A systematic review and meta-analysis.
    PLoS One. 2017;12:e0179680.
    PubMed     Text format     Abstract available


  92. YAGI S, Koh Y, Akamatsu H, Kanai K, et al
    Development of an automated size-based filtration system for isolation of circulating tumor cells in lung cancer patients.
    PLoS One. 2017;12:e0179744.
    PubMed     Text format     Abstract available


  93. BEN-LULU S, Ziv T, Weisman-Shomer P, Benhar M, et al
    Correction: Nitrosothiol-Trapping-Based Proteomic Analysis of S-Nitrosylation in Human Lung Carcinoma Cells.
    PLoS One. 2017;12:e0179803.
    PubMed     Text format     Abstract available


  94. SCHMIDT LH, Brand C, Stucke-Ring J, Schliemann C, et al
    Potential therapeutic impact of CD13 expression in non-small cell lung cancer.
    PLoS One. 2017;12:e0177146.
    PubMed     Text format     Abstract available


  95. LOISELLE JJ, Roy JG, Sutherland LC
    RBM10 promotes transformation-associated processes in small cell lung cancer and is directly regulated by RBM5.
    PLoS One. 2017;12:e0180258.
    PubMed     Text format     Abstract available


  96. DE MARCO C, Laudanna C, Rinaldo N, Oliveira DM, et al
    Specific gene expression signatures induced by the multiple oncogenic alterations that occur within the PTEN/PI3K/AKT pathway in lung cancer.
    PLoS One. 2017;12:e0178865.
    PubMed     Text format     Abstract available


  97. LEE AF, Chen MC, Chen CJ, Yang CJ, et al
    Reverse epithelial-mesenchymal transition contributes to the regain of drug sensitivity in tyrosine kinase inhibitor-resistant non-small cell lung cancer cells.
    PLoS One. 2017;12:e0180383.
    PubMed     Text format     Abstract available


  98. GUISIER F, Bohn P, Patout M, Piton N, et al
    In- and ex-vivo molecular imaging of apoptosis to assess sensitivity of non-small cell lung cancer to EGFR inhibitors using probe-based confocal laser endomicroscopy.
    PLoS One. 2017;12:e0180576.
    PubMed     Text format     Abstract available


  99. POWELL AC, Mirhadi AJ, Loy BA, Happe LE, et al
    Presentation at computed tomography (CT) scan of the thorax and first year diagnostic and treatment utilization among patients diagnosed with lung cancer.
    PLoS One. 2017;12:e0181319.
    PubMed     Text format     Abstract available


  100. GOTO A, Tanaka M, Yoshida M, Umakoshi M, et al
    The low expression of miR-451 predicts a worse prognosis in non-small cell lung cancer cases.
    PLoS One. 2017;12:e0181270.
    PubMed     Text format     Abstract available


  101. SAUSVILLE LN, Jones CC, Aldrich MC, Blot WJ, et al
    Genetic variation in the eicosanoid pathway is associated with non-small-cell lung cancer (NSCLC) survival.
    PLoS One. 2017;12:e0180471.
    PubMed     Text format     Abstract available


  102. LIU PL, Liu WL, Chang JM, Chen YH, et al
    MicroRNA-200c inhibits epithelial-mesenchymal transition, invasion, and migration of lung cancer by targeting HMGB1.
    PLoS One. 2017;12:e0180844.
    PubMed     Text format     Abstract available


  103. MESSARITAKIS I, Politaki E, Kotsakis A, Dermitzaki EK, et al
    Phenotypic characterization of circulating tumor cells in the peripheral blood of patients with small cell lung cancer.
    PLoS One. 2017;12:e0181211.
    PubMed     Text format     Abstract available


  104. SILVA EM, Mariano VS, Pastrez PRA, Pinto MC, et al
    High systemic IL-6 is associated with worse prognosis in patients with non-small cell lung cancer.
    PLoS One. 2017;12:e0181125.
    PubMed     Text format     Abstract available


  105. TANG ZM, Ling ZG, Wang CM, Wu YB, et al
    Serum tumor-associated autoantibodies as diagnostic biomarkers for lung cancer: A systematic review and meta-analysis.
    PLoS One. 2017;12:e0182117.
    PubMed     Text format     Abstract available


  106. BANJARA M, Ghosh C, Dadas A, Mazzone P, et al
    Detection of brain-directed autoantibodies in the serum of non-small cell lung cancer patients.
    PLoS One. 2017;12:e0181409.
    PubMed     Text format     Abstract available


  107. SARIN N, Engel F, Kalayda GV, Mannewitz M, et al
    Cisplatin resistance in non-small cell lung cancer cells is associated with an abrogation of cisplatin-induced G2/M cell cycle arrest.
    PLoS One. 2017;12:e0181081.
    PubMed     Text format     Abstract available


  108. PATNAIK SK, Kannisto ED, Mallick R, Vachani A, et al
    Whole blood microRNA expression may not be useful for screening non-small cell lung cancer.
    PLoS One. 2017;12:e0181926.
    PubMed     Text format     Abstract available


  109. AL-SAAD S, Richardsen E, Kilvaer TK, Donnem T, et al
    The impact of MET, IGF-1, IGF1R expression and EGFR mutations on survival of patients with non-small-cell lung cancer.
    PLoS One. 2017;12:e0181527.
    PubMed     Text format     Abstract available


  110. OH TK, Jeon JH, Lee JM, Kim MS, et al
    Investigation of opioid use and long-term oncologic outcomes for non-small cell lung cancer patients treated with surgery.
    PLoS One. 2017;12:e0181672.
    PubMed     Text format     Abstract available


  111. KOLEK V, Grygarkova I, Koubkova L, Skrickova J, et al
    Carboplatin with intravenous and subsequent oral administration of vinorelbine in resected non-small-cell-lung cancer in real-world set-up.
    PLoS One. 2017;12:e0181803.
    PubMed     Text format     Abstract available


  112. GONG X, Liu J, Zhang D, Yang D, et al
    GLIPR1 modulates the response of cisplatin-resistant human lung cancer cells to cisplatin.
    PLoS One. 2017;12:e0182410.
    PubMed     Text format     Abstract available


  113. LIU L, He Y, Ge G, Li L, et al
    Lactate dehydrogenase and creatine kinase as poor prognostic factors in lung cancer: A retrospective observational study.
    PLoS One. 2017;12:e0182168.
    PubMed     Text format     Abstract available


  114. PELAEZ R, Morales X, Salvo E, Garasa S, et al
    beta3 integrin expression is required for invadopodia-mediated ECM degradation in lung carcinoma cells.
    PLoS One. 2017;12:e0181579.
    PubMed     Text format     Abstract available


  115. MIRET M, Horvath-Puho E, Deruaz-Luyet A, Sorensen HT, et al
    Potential paraneoplastic syndromes and selected autoimmune conditions in patients with non-small cell lung cancer and small cell lung cancer: A population-based cohort study.
    PLoS One. 2017;12:e0181564.
    PubMed     Text format     Abstract available


  116. TONG M, Wang J, Jiang N, Pan H, et al
    Correlation between p-STAT3 overexpression and prognosis in lung cancer: A systematic review and meta-analysis.
    PLoS One. 2017;12:e0182282.
    PubMed     Text format     Abstract available


  117. SCHMIDT LH, Brand C, Stucke-Ring J, Schliemann C, et al
    Correction: Potential therapeutic impact of CD13 expression in non-small cell lung cancer.
    PLoS One. 2017;12:e0183201.
    PubMed     Text format     Abstract available


  118. CHEN B, Yang L, Zhang R, Gan Y, et al
    Hyperphosphorylation of RPS6KB1, rather than overexpression, predicts worse prognosis in non-small cell lung cancer patients.
    PLoS One. 2017;12:e0182891.
    PubMed     Text format     Abstract available


  119. CHENG CC, Chang J, Huang SC, Lin HC, et al
    YM155 as an inhibitor of cancer stemness simultaneously inhibits autophosphorylation of epidermal growth factor receptor and G9a-mediated stemness in lung cancer cells.
    PLoS One. 2017;12:e0182149.
    PubMed     Text format     Abstract available


  120. NAKANO T, Kanai Y, Amano Y, Yoshimoto T, et al
    Establishment of highly metastatic KRAS mutant lung cancer cell sublines in long-term three-dimensional low attachment cultures.
    PLoS One. 2017;12:e0181342.
    PubMed     Text format     Abstract available


  121. PILYUGIN M, Descloux P, Andre PA, Laszlo V, et al
    BARD1 serum autoantibodies for the detection of lung cancer.
    PLoS One. 2017;12:e0182356.
    PubMed     Text format     Abstract available


  122. KIM EK, Kim KA, Lee CY, Shim HS, et al
    The frequency and clinical impact of HER2 alterations in lung adenocarcinoma.
    PLoS One. 2017;12:e0171280.
    PubMed     Text format     Abstract available


  123. WANICHTHANARAK K, Fan S, Grapov D, Barupal DK, et al
    Metabox: A Toolbox for Metabolomic Data Analysis, Interpretation and Integrative Exploration.
    PLoS One. 2017;12:e0171046.
    PubMed     Text format     Abstract available


  124. ORTIZ-ZAPATER E, Lee RW, Owen W, Weitsman G, et al
    MET-EGFR dimerization in lung adenocarcinoma is dependent on EGFR mtations and altered by MET kinase inhibition.
    PLoS One. 2017;12:e0170798.
    PubMed     Text format     Abstract available


  125. HARATI S, Cooper LA, Moran JD, Giuste FO, et al
    MEDICI: Mining Essentiality Data to Identify Critical Interactions for Cancer Drug Target Discovery and Development.
    PLoS One. 2017;12:e0170339.
    PubMed     Text format     Abstract available


  126. FANG Y, Zhang C, Wu T, Wang Q, et al
    Transcriptome Sequencing Reveals Key Pathways and Genes Associated with Cisplatin Resistance in Lung Adenocarcinoma A549 Cells.
    PLoS One. 2017;12:e0170609.
    PubMed     Text format     Abstract available


  127. NIKOLOVSKA K, Spillmann D, Haier J, Ladanyi A, et al
    Melanoma Cell Adhesion and Migration Is Modulated by the Uronyl 2-O Sulfotransferase.
    PLoS One. 2017;12:e0170054.
    PubMed     Text format     Abstract available


  128. KISELEVA R, Greineder CF, Villa CH, Hood ED, et al
    Mechanism of Collaborative Enhancement of Binding of Paired Antibodies to Distinct Epitopes of Platelet Endothelial Cell Adhesion Molecule-1.
    PLoS One. 2017;12:e0169537.
    PubMed     Text format     Abstract available


  129. ALSUBAIE N, Trahearn N, Raza SE, Snead D, et al
    Stain Deconvolution Using Statistical Analysis of Multi-Resolution Stain Colour Representation.
    PLoS One. 2017;12:e0169875.
    PubMed     Text format     Abstract available


  130. CHOUAID C, Debieuvre D, Durand-Zaleski I, Fernandes J, et al
    Survival inequalities in patients with lung cancer in France: A nationwide cohort study (the TERRITOIRE Study).
    PLoS One. 2017;12:e0182798.
    PubMed     Text format     Abstract available


  131. SHIN J, Song SY, Ahn HS, An BC, et al
    Integrative analysis for the discovery of lung cancer serological markers and validation by MRM-MS.
    PLoS One. 2017;12:e0183896.
    PubMed     Text format     Abstract available


  132. JOVELET C, Madic J, Remon J, Honore A, et al
    Crystal digital droplet PCR for detection and quantification of circulating EGFR sensitizing and resistance mutations in advanced non-small cell lung cancer.
    PLoS One. 2017;12:e0183319.
    PubMed     Text format     Abstract available


  133. CHEN L, Lu J, Huang T, Cai YD, et al
    A computational method for the identification of candidate drugs for non-small cell lung cancer.
    PLoS One. 2017;12:e0183411.
    PubMed     Text format     Abstract available


  134. YANG JH, Li XY, Wang X, Hou WJ, et al
    Long-term persistent infection of HPV 16 E6 up-regulate SP1 and hTERT by inhibiting LKB1 in lung cancer cells.
    PLoS One. 2017;12:e0182775.
    PubMed     Text format     Abstract available


  135. KONG GM, Yu M, Gu Z, Chen Z, et al
    Selective small-chemical inhibitors of protein arginine methyltransferase 5 with anti-lung cancer activity.
    PLoS One. 2017;12:e0181601.
    PubMed     Text format     Abstract available


  136. ZHANG C, Wei B, Li P, Yang K, et al
    Prognostic value of plasma EGFR ctDNA in NSCLC patients treated with EGFR-TKIs.
    PLoS One. 2017;12:e0173524.
    PubMed     Text format     Abstract available


  137. WIEGERING A, Riegel J, Wagner J, Kunzmann V, et al
    The impact of pulmonary metastasectomy in patients with previously resected colorectal cancer liver metastases.
    PLoS One. 2017;12:e0173933.
    PubMed     Text format     Abstract available


  138. ASOR E, Stav MY, Simon E, Fahoum I, et al
    Risk for molecular contamination of tissue samples evaluated for targeted anti-cancer therapy.
    PLoS One. 2017;12:e0173760.
    PubMed     Text format     Abstract available


  139. ECHTLER K, Konrad I, Lorenz M, Schneider S, et al
    Platelet GPIIb supports initial pulmonary retention but inhibits subsequent proliferation of melanoma cells during hematogenic metastasis.
    PLoS One. 2017;12:e0172788.
    PubMed     Text format     Abstract available


  140. PUNIA R, Raina K, Agarwal R, Singh RP, et al
    Acacetin enhances the therapeutic efficacy of doxorubicin in non-small-cell lung carcinoma cells.
    PLoS One. 2017;12:e0182870.
    PubMed     Text format     Abstract available


  141. VAN DER WEKKEN AJ, Kuiper JL, Saber A, Terpstra MM, et al
    Overall survival in EGFR mutated non-small-cell lung cancer patients treated with afatinib after EGFR TKI and resistant mechanisms upon disease progression.
    PLoS One. 2017;12:e0182885.
    PubMed     Text format     Abstract available


  142. HSU MK, Lin HY, Chen FC
    NMD Classifier: A reliable and systematic classification tool for nonsense-mediated decay events.
    PLoS One. 2017;12:e0174798.
    PubMed     Text format     Abstract available


  143. PARK JE, Chun SE, Reichel D, Min JS, et al
    Polymer micelle formulation for the proteasome inhibitor drug carfilzomib: Anticancer efficacy and pharmacokinetic studies in mice.
    PLoS One. 2017;12:e0173247.
    PubMed     Text format     Abstract available


  144. JIN J, Hu K, Zhou Y, Li W, et al
    Clinical utility of the modified Glasgow prognostic score in lung cancer: A meta-analysis.
    PLoS One. 2017;12:e0184412.
    PubMed     Text format     Abstract available


  145. CAO X, MacNaughton P, Laurent JC, Allen JG, et al
    Radon-induced lung cancer deaths may be overestimated due to failure to account for confounding by exposure to diesel engine exhaust in BEIR VI miner studies.
    PLoS One. 2017;12:e0184298.
    PubMed     Text format     Abstract available


  146. DE BIASE D, Genestreti G, Visani M, Acquaviva G, et al
    The percentage of Epidermal Growth Factor Receptor (EGFR)-mutated neoplastic cells correlates to response to tyrosine kinase inhibitors in lung adenocarcinoma.
    PLoS One. 2017;12:e0177822.
    PubMed     Text format     Abstract available


  147. HSIEH CC, Sun YH, Lin SW, Yeh YC, et al
    Surgical outcomes of pulmonary mucoepidermoid carcinoma: A review of 41 cases.
    PLoS One. 2017;12:e0176918.
    PubMed     Text format     Abstract available


  148. LEE DH, Hwang SH, Lim MK, Oh JK, et al
    Performance of urine cotinine and hypomethylation of AHRR and F2RL3 as biomarkers for smoking exposure in a population-based cohort.
    PLoS One. 2017;12:e0176783.
    PubMed     Text format     Abstract available


  149. CAI G, Xiao F, Cheng C, Li Y, et al
    Population effect model identifies gene expression predictors of survival outcomes in lung adenocarcinoma for both Caucasian and Asian patients.
    PLoS One. 2017;12:e0175850.
    PubMed     Text format     Abstract available


  150. AGRAWAL V, Coroller TP, Hou Y, Lee SW, et al
    Lymph node volume predicts survival but not nodal clearance in Stage IIIA-IIIB NSCLC.
    PLoS One. 2017;12:e0174268.
    PubMed     Text format     Abstract available


  151. LYNCH CM, van Berkel VH, Frieboes HB
    Application of unsupervised analysis techniques to lung cancer patient data.
    PLoS One. 2017;12:e0184370.
    PubMed     Text format     Abstract available


  152. CAI NL, Lau ATY, Yu FY, Wu DD, et al
    Purification and characterization of a highly specific polyclonal antibody against human extracellular signal-regulated kinase 8 and its detection in lung cancer.
    PLoS One. 2017;12:e0184755.
    PubMed     Text format     Abstract available


  153. SHEN Z, Wang H, Xi W, Deng X, et al
    Multi-phase simultaneous segmentation of tumor in lung 4D-CT data with context information.
    PLoS One. 2017;12:e0178411.
    PubMed     Text format     Abstract available


  154. KOO HJ, Kim MY, Koo JH, Sung YS, et al
    Computerized margin and texture analyses for differentiating bacterial pneumonia and invasive mucinous adenocarcinoma presenting as consolidation.
    PLoS One. 2017;12:e0177379.
    PubMed     Text format     Abstract available


  155. ZHAO XK, Mao YM, Meng H, Song X, et al
    Shared susceptibility loci at 2q33 region for lung and esophageal cancers in high-incidence areas of esophageal cancer in northern China.
    PLoS One. 2017;12:e0177504.
    PubMed     Text format     Abstract available


  156. FARQUHAR M, Penfold C, Benson J, Lovick R, et al
    Six key topics informal carers of patients with breathlessness in advanced disease want to learn about and why: MRC phase I study to inform an educational intervention.
    PLoS One. 2017;12:e0177081.
    PubMed     Text format     Abstract available


  157. WANG XF, Zhu YT, Wang JJ, Zeng DX, et al
    The prognostic value of interleukin-17 in lung cancer: A systematic review with meta-analysis based on Chinese patients.
    PLoS One. 2017;12:e0185168.
    PubMed     Text format     Abstract available


  158. ELLSWORTH SG, Rabatic BM, Chen J, Zhao J, et al
    Principal component analysis identifies patterns of cytokine expression in non-small cell lung cancer patients undergoing definitive radiation therapy.
    PLoS One. 2017;12:e0183239.
    PubMed     Text format     Abstract available


  159. WANG C, Zhang X, Li H, Li X, et al
    Quantitative thyroglobulin response to radioactive iodine treatment in predicting radioactive iodine-refractory thyroid cancer with pulmonary metastasis.
    PLoS One. 2017;12:e0179664.
    PubMed     Text format     Abstract available


  160. WANG L, Tang C, Xu B, Yang L, et al
    Mass spectrometry-based serum peptidome profiling accurately and reliably predicts outcomes of pemetrexed plus platinum chemotherapy in patients with advanced lung adenocarcinoma.
    PLoS One. 2017;12:e0179000.
    PubMed     Text format     Abstract available


  161. YIP SSF, Parmar C, Blezek D, Estepar RSJ, et al
    Application of the 3D slicer chest imaging platform segmentation algorithm for large lung nodule delineation.
    PLoS One. 2017;12:e0178944.
    PubMed     Text format     Abstract available


  162. KEARNEY P, Hunsucker SW, Li XJ, Porter A, et al
    An integrated risk predictor for pulmonary nodules.
    PLoS One. 2017;12:e0177635.
    PubMed     Text format     Abstract available


  163. KEE JY, Han YH, Kim DS, Mun JG, et al
    beta-Lapachone suppresses the lung metastasis of melanoma via the MAPK signaling pathway.
    PLoS One. 2017;12:e0176937.
    PubMed     Text format     Abstract available


  164. WANG T, Moon JY, Wu Y, Amos CI, et al
    Pleiotropy of genetic variants on obesity and smoking phenotypes: Results from the Oncoarray Project of The International Lung Cancer Consortium.
    PLoS One. 2017;12:e0185660.
    PubMed     Text format     Abstract available


  165. SHAN S, She J, Xue ZQ, Su CX, et al
    Clinical characteristics and survival of lung cancer patients associated with multiple primary malignancies.
    PLoS One. 2017;12:e0185485.
    PubMed     Text format     Abstract available


  166. WANG F, Xu X, Yang J, Min L, et al
    Height and lung cancer risk: A meta-analysis of observational studies.
    PLoS One. 2017;12:e0185316.
    PubMed     Text format     Abstract available


  167. CIRCU M, Cardelli J, Barr M, O'Byrne K, et al
    Modulating lysosomal function through lysosome membrane permeabilization or autophagy suppression restores sensitivity to cisplatin in refractory non-small-cell lung cancer cells.
    PLoS One. 2017;12:e0184922.
    PubMed     Text format     Abstract available


  168. NOWICKI-OSUCH K, Li Y, Challinor M, Gerrard DT, et al
    EINCR1 is an EGF inducible lincRNA overexpressed in lung adenocarcinomas.
    PLoS One. 2017;12:e0181902.
    PubMed     Text format     Abstract available


  169. PIRIE-SHEPHERD SR, Painter C, Whalen P, Vizcarra P, et al
    Detecting expression of 5T4 in CTCs and tumor samples from NSCLC patients.
    PLoS One. 2017;12:e0179561.
    PubMed     Text format     Abstract available


  170. TAKADA K, Okamoto T, Tominaga M, Teraishi K, et al
    Clinical implications of the novel cytokine IL-38 expressed in lung adenocarcinoma: Possible association with PD-L1 expression.
    PLoS One. 2017;12:e0181598.
    PubMed     Text format     Abstract available


  171. CHOI BH, Young HS, Quan YH, Rho J, et al
    Real-time computed tomography fluoroscopy-guided solitary lung tumor model in a rabbit.
    PLoS One. 2017;12:e0179220.
    PubMed     Text format     Abstract available


  172. LENDECKEL D, Kromrey ML, Ittermann T, Schafer S, et al
    Pulmonary emphysema is a predictor of pneumothorax after CT-guided transthoracic pulmonary biopsies of pulmonary nodules.
    PLoS One. 2017;12:e0178078.
    PubMed     Text format     Abstract available


  173. MINCHOM A, Thavasu P, Ahmad Z, Stewart A, et al
    A study of PD-L1 expression in KRAS mutant non-small cell lung cancer cell lines exposed to relevant targeted treatments.
    PLoS One. 2017;12:e0186106.
    PubMed     Text format     Abstract available


  174. ILIE M, Khambata-Ford S, Copie-Bergman C, Huang L, et al
    Use of the 22C3 anti-PD-L1 antibody to determine PD-L1 expression in multiple automated immunohistochemistry platforms.
    PLoS One. 2017;12:e0183023.
    PubMed     Text format     Abstract available


  175. MUSCELLA A, Vetrugno C, Cossa LG, Antonaci G, et al
    Apoptosis by [Pt(O,O'-acac)(gamma-acac)(DMS)] requires PKC-delta mediated p53 activation in malignant pleural mesothelioma.
    PLoS One. 2017;12:e0181114.
    PubMed     Text format     Abstract available


  176. YVOREL V, Patoir A, Casteillo F, Tissot C, et al
    PD-L1 expression in pleomorphic, spindle cell and giant cell carcinoma of the lung is related to TTF-1, p40 expression and might indicate a worse prognosis.
    PLoS One. 2017;12:e0180346.
    PubMed     Text format     Abstract available


  177. BORIN TF, Shankar A, Angara K, Rashid MH, et al
    HET0016 decreases lung metastasis from breast cancer in immune-competent mouse model.
    PLoS One. 2017;12:e0178830.
    PubMed     Text format     Abstract available


  178. KASPI E, Frankel D, Guinde J, Perrin S, et al
    Low lamin A expression in lung adenocarcinoma cells from pleural effusions is a pejorative factor associated with high number of metastatic sites and poor Performance status.
    PLoS One. 2017;12:e0183136.
    PubMed     Text format     Abstract available


  179. KROSNICK JA, Malhotra N, Mo CH, Bruera EF, et al
    Perceptions of health risks of cigarette smoking: A new measure reveals widespread misunderstanding.
    PLoS One. 2017;12:e0182063.
    PubMed     Text format     Abstract available


  180. TUDOR RA, D'Silva A, Tremblay A, MacEachern P, et al
    Beyond disease-progression: Clinical outcomes after EGFR-TKIs in a cohort of EGFR mutated NSCLC patients.
    PLoS One. 2017;12:e0181867.
    PubMed     Text format     Abstract available


  181. JIN C, Zhang G, Zhang Y, Hua P, et al
    Isoalantolactone induces intrinsic apoptosis through p53 signaling pathway in human lung squamous carcinoma cells.
    PLoS One. 2017;12:e0181731.
    PubMed     Text format     Abstract available


  182. YU PY, Gardner HL, Roberts R, Cam H, et al
    Target specificity, in vivo pharmacokinetics, and efficacy of the putative STAT3 inhibitor LY5 in osteosarcoma, Ewing's sarcoma, and rhabdomyosarcoma.
    PLoS One. 2017;12:e0181885.
    PubMed     Text format     Abstract available


  183. NAKAMURA S, Hayashi K, Imaoka Y, Kitamura Y, et al
    Intratumoral heterogeneity of programmed cell death ligand-1 expression is common in lung cancer.
    PLoS One. 2017;12:e0186192.
    PubMed     Text format     Abstract available


  184. PEARCE A, Haas M, Viney R, Pearson SA, et al
    Incidence and severity of self-reported chemotherapy side effects in routine care: A prospective cohort study.
    PLoS One. 2017;12:e0184360.
    PubMed     Text format     Abstract available


  185. D'HOOGHE JNS, Goorsenberg AWM, de Bruin DM, Roelofs JJTH, et al
    Optical coherence tomography for identification and quantification of human airway wall layers.
    PLoS One. 2017;12:e0184145.
    PubMed     Text format     Abstract available


  186. LIAO HF, Pan CH, Chou PY, Chen YF, et al
    Toxicological effects of NCKU-21, a phenanthrene derivative, on cell growth and migration of A549 and CL1-5 human lung adenocarcinoma cells.
    PLoS One. 2017;12:e0185021.
    PubMed     Text format     Abstract available


  187. LAMBERT A, Jarlier M, Gourgou Bourgade S, Conroy T, et al
    Response to FOLFIRINOX by gender in patients with metastatic pancreatic cancer: Results from the PRODIGE 4/ ACCORD 11 randomized trial.
    PLoS One. 2017;12:e0183288.
    PubMed     Text format     Abstract available


  188. SUTTON BC, Birse RT, Maggert K, Ray T, et al
    Assessment of common somatic mutations of EGFR, KRAS, BRAF, NRAS in pulmonary non-small cell carcinoma using iPLEX(R) HS, a new highly sensitive assay for the MassARRAY(R) System.
    PLoS One. 2017;12:e0183715.
    PubMed     Text format     Abstract available


  189. BUONOMO OC, Caredda E, Portarena I, Vanni G, et al
    New insights into the metastatic behavior after breast cancer surgery, according to well-established clinicopathological variables and molecular subtypes.
    PLoS One. 2017;12:e0184680.
    PubMed     Text format     Abstract available


  190. HUANG JY, Wang R, Gao YT, Yuan JM, et al
    ABO blood type and the risk of cancer - Findings from the Shanghai Cohort Study.
    PLoS One. 2017;12:e0184295.
    PubMed     Text format     Abstract available


  191. KWIECIEN JM, Bassey-Archibong BI, Dabrowski W, Rayner LG, et al
    Loss of Kaiso expression in breast cancer cells prevents intra-vascular invasion in the lung and secondary metastasis.
    PLoS One. 2017;12:e0183883.
    PubMed     Text format     Abstract available


  192. FORNARO L, Vivaldi C, Lin D, Xue H, et al
    Prognostic relevance of a T-type calcium channels gene signature in solid tumours: A correlation ready for clinical validation.
    PLoS One. 2017;12:e0182818.
    PubMed     Text format     Abstract available


  193. LI Y, Xu H, Su S, Ye J, et al
    Clinical validation of a highly sensitive assay to detect EGFR mutations in plasma cell-free DNA from patients with advanced lung adenocarcinoma.
    PLoS One. 2017;12:e0183331.
    PubMed     Text format     Abstract available


  194. KWAK KM, Paek D, Hwang SS, Ju YS, et al
    Estimated future incidence of malignant mesothelioma in South Korea: Projection from 2014 to 2033.
    PLoS One. 2017;12:e0183404.
    PubMed     Text format     Abstract available


  195. NOGUEIRA JORGE NA, Wajnberg G, Ferreira CG, de Sa Carvalho B, et al
    snoRNA and piRNA expression levels modified by tobacco use in women with lung adenocarcinoma.
    PLoS One. 2017;12:e0183410.
    PubMed     Text format     Abstract available


  196. VANDEREYKEN M, Jacques S, Van Overmeire E, Amand M, et al
    Dusp3 deletion in mice promotes experimental lung tumour metastasis in a macrophage dependent manner.
    PLoS One. 2017;12:e0185786.
    PubMed     Text format     Abstract available


  197. MOON MH, Beck KS, Moon YK, Park JK, et al
    Incidence and clinical features of the incidentally found vascular stump thrombus during routine follow up after oncologic lung surgery.
    PLoS One. 2017;12:e0185140.
    PubMed     Text format     Abstract available


  198. JIANG R, Dong X, Zhu W, Duan Q, et al
    Combining PET/CT with serum tumor markers to improve the evaluation of histological type of suspicious lung cancers.
    PLoS One. 2017;12:e0184338.
    PubMed     Text format     Abstract available


  199. KIND M, Klukowska-Rotzler J, Berezowska S, Arcaro A, et al
    Questioning the role of selected somatic PIK3C2B mutations in squamous non-small cell lung cancer oncogenesis.
    PLoS One. 2017;12:e0187308.
    PubMed     Text format     Abstract available


  200. FORCELLA M, Oldani M, Epistolio S, Freguia S, et al
    Non-small cell lung cancer (NSCLC), EGFR downstream pathway activation and TKI targeted therapies sensitivity: Effect of the plasma membrane-associated NEU3.
    PLoS One. 2017;12:e0187289.
    PubMed     Text format     Abstract available


  201. SCHMIDT LH, Heitkotter B, Schulze AB, Schliemann C, et al
    Prostate specific membrane antigen (PSMA) expression in non-small cell lung cancer.
    PLoS One. 2017;12:e0186280.
    PubMed     Text format     Abstract available


  202. OTOSHI T, Kataoka Y, Ikegaki S, Saito E, et al
    Pleural effusion biomarkers and computed tomography findings in diagnosing malignant pleural mesothelioma: A retrospective study in a single center.
    PLoS One. 2017;12:e0185850.
    PubMed     Text format     Abstract available


  203. ZHAO J, Dinkel J, Warth A, Penzel R, et al
    CT characteristics in pulmonary adenocarcinoma with epidermal growth factor receptor mutation.
    PLoS One. 2017;12:e0182741.
    PubMed     Text format     Abstract available


  204. LIU K, Zheng D, Xu G, Du Z, et al
    Local thoracic therapy improve prognosis for stage IV non-small cell lung cancer patients combined with chemotherapy: A Surveillance, Epidemiology, and End Results database analysis.
    PLoS One. 2017;12:e0187350.
    PubMed     Text format     Abstract available


  205. ARNS A, Blessing M, Fleckenstein J, Stsepankou D, et al
    Phantom-based evaluation of dose exposure of ultrafast combined kV-MV-CBCT towards clinical implementation for IGRT of lung cancer.
    PLoS One. 2017;12:e0187710.
    PubMed     Text format     Abstract available


  206. CHEN YF, Yuan A, Cho KH, Lu YC, et al
    Functional evaluation of therapeutic response of HCC827 lung cancer to bevacizumab and erlotinib targeted therapy using dynamic contrast-enhanced and diffusion-weighted MRI.
    PLoS One. 2017;12:e0187824.
    PubMed     Text format     Abstract available


  207. JABS V, Edlund K, Konig H, Grinberg M, et al
    Integrative analysis of genome-wide gene copy number changes and gene expression in non-small cell lung cancer.
    PLoS One. 2017;12:e0187246.
    PubMed     Text format     Abstract available


  208. FRENZEL T, Hoffmann B, Schmitz R, Bethge A, et al
    Radiotherapy and chemotherapy change vessel tree geometry and metastatic spread in a small cell lung cancer xenograft mouse tumor model.
    PLoS One. 2017;12:e0187144.
    PubMed     Text format     Abstract available


  209. SEO SR, Lee HM, Choi HS, Kim WT, et al
    Enhanced expression of cell-surface B-cell receptor-associated protein 31 contributes to poor survival of non-small cell lung carcinoma cells.
    PLoS One. 2017;12:e0188075.
    PubMed     Text format     Abstract available


  210. SIKDAR S, Datta S, Datta S
    EAMA: Empirically adjusted meta-analysis for large-scale simultaneous hypothesis testing in genomic experiments.
    PLoS One. 2017;12:e0187287.
    PubMed     Text format     Abstract available


  211. LIN CY, Wu YM, Hsieh MH, Wang CW, et al
    Prognostic implication of EGFR gene mutations and histological classification in patients with resected stage I lung adenocarcinoma.
    PLoS One. 2017;12:e0186567.
    PubMed     Text format     Abstract available


  212. JIAO DM, Yan L, Wang LS, Hu HZ, et al
    Retraction: Exploration of inhibitory mechanisms of curcumin in lung cancer metastasis using a miRNA- transcription factor-target gene network.
    PLoS One. 2017;12:e0189070.
    PubMed     Text format    


  213. LIU B, Zhao Y, Yuan J, Zeng L, et al
    Elevated N-telopeptide as a potential diagnostic marker for bone metastasis in lung cancer: A meta-analysis.
    PLoS One. 2017;12:e0187860.
    PubMed     Text format     Abstract available


  214. VAN RIEL SJ, Ciompi F, Winkler Wille MM, Dirksen A, et al
    Malignancy risk estimation of pulmonary nodules in screening CTs: Comparison between a computer model and human observers.
    PLoS One. 2017;12:e0185032.
    PubMed     Text format     Abstract available


  215. LI R, Zhang Y, Yuan Y, Lin Q, et al
    Dosimetric comparison of CT-guided iodine-125 seed stereotactic brachytherapy and stereotactic body radiation therapy in the treatment of NSCLC.
    PLoS One. 2017;12:e0187390.
    PubMed     Text format     Abstract available


  216. ZHOU S, Wang P, Su X, Chen J, et al
    High ECT2 expression is an independent prognostic factor for poor overall survival and recurrence-free survival in non-small cell lung adenocarcinoma.
    PLoS One. 2017;12:e0187356.
    PubMed     Text format     Abstract available


  217. MARCOS-VADILLO E, Garcia-Sanchez A, Sanz C, Davila I, et al
    PTGDR gene expression and response to dexamethasone treatment in an in vitro model.
    PLoS One. 2017;12:e0186957.
    PubMed     Text format     Abstract available


  218. ISAKSSON S, Jonsson P, Monsef N, Brunnstrom H, et al
    CA 19-9 and CA 125 as potential predictors of disease recurrence in resectable lung adenocarcinoma.
    PLoS One. 2017;12:e0186284.
    PubMed     Text format     Abstract available


  219. BRINKHOF S, Groen HJM, Siesling SS, IJzerman MJ, et al
    Resource utilization in lung cancer diagnostic procedures: Current use and budget consequences.
    PLoS One. 2017;12:e0189251.
    PubMed     Text format     Abstract available


  220. KIM ES, Baran AM, Mondo EL, Rodgers TD, et al
    Risk of thromboembolism in cisplatin versus carboplatin-treated patients with lung cancer.
    PLoS One. 2017;12:e0189410.
    PubMed     Text format     Abstract available


  221. ZHANG H, Diao H, Jia L, Yuan Y, et al
    Proteus mirabilis inhibits cancer growth and pulmonary metastasis in a mouse breast cancer model.
    PLoS One. 2017;12:e0188960.
    PubMed     Text format     Abstract available


  222. OOI CC, Mantalas GL, Koh W, Neff NF, et al
    High-throughput full-length single-cell mRNA-seq of rare cells.
    PLoS One. 2017;12:e0188510.
    PubMed     Text format     Abstract available


  223. KANG G, Liu K, Hou B, Zhang N, et al
    3D multi-view convolutional neural networks for lung nodule classification.
    PLoS One. 2017;12:e0188290.
    PubMed     Text format     Abstract available


  224. HAN KN, Kim HK, Choi YH
    Midterm outcomes of single port thoracoscopic surgery for major pulmonary resection.
    PLoS One. 2017;12:e0186857.
    PubMed     Text format     Abstract available


  225. KIM H, Park CM, Keam B, Park SJ, et al
    The prognostic value of CT radiomic features for patients with pulmonary adenocarcinoma treated with EGFR tyrosine kinase inhibitors.
    PLoS One. 2017;12:e0187500.
    PubMed     Text format     Abstract available


  226. GALLARDO-ESTRELLA L, Pompe E, de Jong PA, Jacobs C, et al
    Normalized emphysema scores on low dose CT: Validation as an imaging biomarker for mortality.
    PLoS One. 2017;12:e0188902.
    PubMed     Text format     Abstract available


  227. TAKAHASHI Y, Yasui T, Tamari K, Minami K, et al
    Radiation enhanced the local and distant anti-tumor efficacy in dual immune checkpoint blockade therapy in osteosarcoma.
    PLoS One. 2017;12:e0189697.
    PubMed     Text format     Abstract available


  228. SABIR SH, Krishnamurthy S, Gupta S, Mills GB, et al
    Characteristics of percutaneous core biopsies adequate for next generation genomic sequencing.
    PLoS One. 2017;12:e0189651.
    PubMed     Text format     Abstract available


    January 2016
  229. LOHINAI Z, Dome P, Szilagyi Z, Ostoros G, et al
    From Bench to Bedside: Attempt to Evaluate Repositioning of Drugs in the Treatment of Metastatic Small Cell Lung Cancer (SCLC).
    PLoS One. 2016;11:e0144797.
    PubMed     Text format     Abstract available


  230. GUERRERA F, Tabbo F, Bessone L, Maletta F, et al
    The Influence of Tissue Ischemia Time on RNA Integrity and Patient-Derived Xenografts (PDX) Engraftment Rate in a Non-Small Cell Lung Cancer (NSCLC) Biobank.
    PLoS One. 2016;11:e0145100.
    PubMed     Text format     Abstract available


  231. LIU J, Dong M, Sun X, Li W, et al
    Prognostic Value of 18F-FDG PET/CT in Surgical Non-Small Cell Lung Cancer: A Meta-Analysis.
    PLoS One. 2016;11:e0146195.
    PubMed     Text format     Abstract available


  232. HAGEDOORN P, Vandenheede H, Willaert D, Vanthomme K, et al
    Regional Inequalities in Lung Cancer Mortality in Belgium at the Beginning of the 21st Century: The Contribution of Individual and Area-Level Socioeconomic Status and Industrial Exposure.
    PLoS One. 2016;11:e0147099.
    PubMed     Text format     Abstract available


  233. YANG Y, Nguyen TT, Jeong MH, Crisan F, et al
    Inhibitory Activity of (+)-Usnic Acid against Non-Small Cell Lung Cancer Cell Motility.
    PLoS One. 2016;11:e0146575.
    PubMed     Text format     Abstract available


  234. YOSHIDA T, Song L, Bai Y, Kinose F, et al
    ZEB1 Mediates Acquired Resistance to the Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer.
    PLoS One. 2016;11:e0147344.
    PubMed     Text format     Abstract available


  235. QIU ZX, Sun RF, Mo XM, Li WM, et al
    The p70S6K Specific Inhibitor PF-4708671 Impedes Non-Small Cell Lung Cancer Growth.
    PLoS One. 2016;11:e0147185.
    PubMed     Text format     Abstract available


  236. MEREDITH SL, Bryant JL, Babur M, Riddell PW, et al
    Irradiation Decreases the Neuroendocrine Biomarker Pro-Opiomelanocortin in Small Cell Lung Cancer Cells In Vitro and In Vivo.
    PLoS One. 2016;11:e0148404.
    PubMed     Text format     Abstract available


  237. HU M, Hu Y, He J, Li B, et al
    Prognostic Value of Basic Fibroblast Growth Factor (bFGF) in Lung Cancer: A Systematic Review with Meta-Analysis.
    PLoS One. 2016;11:e0147374.
    PubMed     Text format     Abstract available


  238. LI W, Wang Y, Zhang Q, Tang L, et al
    Correction: MicroRNA-486 as a Biomarker for Early Diagnosis and Recurrence of Non-Small Cell Lung Cancer.
    PLoS One. 2016;11:e0148589.
    PubMed     Text format     Abstract available


  239. AVILA-MORENO F, Armas-Lopez L, Alvarez-Moran AM, Lopez-Bujanda Z, et al
    Correction: Overexpression of MEOX2 and TWIST1 is Associated with H3K27me3 Levels and Determines Lung Cancer Chemoresistance and Prognosis.
    PLoS One. 2016;11:e0146569.
    PubMed     Text format     Abstract available


  240. MALANGA D, Belmonte S, Colelli F, Scarfo M, et al
    AKT1E17K Is Oncogenic in Mouse Lung and Cooperates with Chemical Carcinogens in Inducing Lung Cancer.
    PLoS One. 2016;11:e0147334.
    PubMed     Text format     Abstract available


  241. LUI NS, Yang YW, van Zante A, Buchanan P, et al
    SULF2 Expression Is a Potential Diagnostic and Prognostic Marker in Lung Cancer.
    PLoS One. 2016;11:e0148911.
    PubMed     Text format     Abstract available


  242. KHAN S, Imran A, Khan AA, Abul Kalam M, et al
    Systems Biology Approaches for the Prediction of Possible Role of Chlamydia pneumoniae Proteins in the Etiology of Lung Cancer.
    PLoS One. 2016;11:e0148530.
    PubMed     Text format     Abstract available


  243. CHEN YM, Lai CH, Chang HC, Chao TY, et al
    Antacid Use and De Novo Brain Metastases in Patients with Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer Who Were Treated Using First-Line First-Generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors.
    PLoS One. 2016;11:e0149722.
    PubMed     Text format     Abstract available


  244. CHANG WH, Ho BC, Hsiao YJ, Chen JS, et al
    JAG1 Is Associated with Poor Survival through Inducing Metastasis in Lung Cancer.
    PLoS One. 2016;11:e0150355.
    PubMed     Text format     Abstract available


  245. CHENG NM, Fang YH, Tsan DL, Hsu CH, et al
    Respiration-Averaged CT for Attenuation Correction of PET Images - Impact on PET Texture Features in Non-Small Cell Lung Cancer Patients.
    PLoS One. 2016;11:e0150509.
    PubMed     Text format     Abstract available


  246. SHERWOOD JL, Corcoran C, Brown H, Sharpe AD, et al
    Optimised Pre-Analytical Methods Improve KRAS Mutation Detection in Circulating Tumour DNA (ctDNA) from Patients with Non-Small Cell Lung Cancer (NSCLC).
    PLoS One. 2016;11:e0150197.
    PubMed     Text format     Abstract available


  247. BAYARRI-LARA C, Ortega FG, Cueto Ladron de Guevara A, Puche JL, et al
    Circulating Tumor Cells Identify Early Recurrence in Patients with Non-Small Cell Lung Cancer Undergoing Radical Resection.
    PLoS One. 2016;11:e0148659.
    PubMed     Text format     Abstract available


  248. HOWE GA, Xiao B, Zhao H, Al-Zahrani KN, et al
    Focal Adhesion Kinase Inhibitors in Combination with Erlotinib Demonstrate Enhanced Anti-Tumor Activity in Non-Small Cell Lung Cancer.
    PLoS One. 2016;11:e0150567.
    PubMed     Text format     Abstract available


  249. REGAN E, Sibley RC, Cenik BK, Silva A, et al
    Identification of Gene Expression Differences between Lymphangiogenic and Non-Lymphangiogenic Non-Small Cell Lung Cancer Cell Lines.
    PLoS One. 2016;11:e0150963.
    PubMed     Text format     Abstract available


  250. BAI XY, Zhang XC, Yang SQ, An SJ, et al
    Blockade of Hedgehog Signaling Synergistically Increases Sensitivity to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small-Cell Lung Cancer Cell Lines.
    PLoS One. 2016;11:e0149370.
    PubMed     Text format     Abstract available


  251. ZHANG Y, Jiang M, Li Q, Liang W, et al
    Chromosome 15q25 (CHRNA3-CHRNB4) Variation Indirectly Impacts Lung Cancer Risk in Chinese Males.
    PLoS One. 2016;11:e0149946.
    PubMed     Text format     Abstract available


  252. LEUNG AW, Hung SS, Backstrom I, Ricaurte D, et al
    Combined Use of Gene Expression Modeling and siRNA Screening Identifies Genes and Pathways Which Enhance the Activity of Cisplatin When Added at No Effect Levels to Non-Small Cell Lung Cancer Cells In Vitro.
    PLoS One. 2016;11:e0150675.
    PubMed     Text format     Abstract available


  253. SAITO K, Nakayama E, Valmori D
    Immune Responses to the Cancer Testis Antigen XAGE-1b in Non Small Cell Lung Cancer Caucasian Patients.
    PLoS One. 2016;11:e0150623.
    PubMed     Text format     Abstract available


  254. LI R, Pu X, Chang JY, Ye Y, et al
    MiRNA-Related Genetic Variations Associated with Radiotherapy-Induced Toxicities in Patients with Locally Advanced Non-Small Cell Lung Cancer.
    PLoS One. 2016;11:e0150467.
    PubMed     Text format     Abstract available


  255. DEDONG C, Huilin X, Anbing H, Ximing X, et al
    The Effect of ShenQi FuZheng Injection in Combination with Chemotherapy versus Chemotherapy Alone on the Improvement of Efficacy and Immune Function in Patients with Advanced Non-Small Cell Lung Cancer: A Meta-Analysis.
    PLoS One. 2016;11:e0152270.
    PubMed     Text format     Abstract available


  256. ZHANG C, Zhang H, Shi J, Wang D, et al
    Trial-Based Cost-Utility Analysis of Icotinib versus Gefitinib as Second-Line Therapy for Advanced Non-Small Cell Lung Cancer in China.
    PLoS One. 2016;11:e0151846.
    PubMed     Text format     Abstract available


  257. ZHANG Q, Gao M, Luo G, Han X, et al
    Enhancement of Radiation Sensitivity in Lung Cancer Cells by a Novel Small Molecule Inhibitor That Targets the beta-Catenin/Tcf4 Interaction.
    PLoS One. 2016;11:e0152407.
    PubMed     Text format     Abstract available


  258. SABER A, van der Wekken AJ, Kerner GS, van den Berge M, et al
    Chronic Obstructive Pulmonary Disease Is Not Associated with KRAS Mutations in Non-Small Cell Lung Cancer.
    PLoS One. 2016;11:e0152317.
    PubMed     Text format     Abstract available


  259. ZHOU YY, Hu ZG, Zeng FJ, Han J, et al
    Clinical Profile of Cyclooxygenase-2 Inhibitors in Treating Non-Small Cell Lung Cancer: A Meta-Analysis of Nine Randomized Clinical Trials.
    PLoS One. 2016;11:e0151939.
    PubMed     Text format     Abstract available


  260. DE GREVE J, Van Meerbeeck J, Vansteenkiste JF, Decoster L, et al
    Prospective Evaluation of First-Line Erlotinib in Advanced Non-Small Cell Lung Cancer (NSCLC) Carrying an Activating EGFR Mutation: A Multicenter Academic Phase II Study in Caucasian Patients (FIELT).
    PLoS One. 2016;11:e0147599.
    PubMed     Text format     Abstract available


  261. LYONS JD, Mittal R, Fay KT, Chen CW, et al
    Murine Lung Cancer Increases CD4+ T Cell Apoptosis and Decreases Gut Proliferative Capacity in Sepsis.
    PLoS One. 2016;11:e0149069.
    PubMed     Text format     Abstract available


  262. CARDNELL RJ, Feng Y, Mukherjee S, Diao L, et al
    Activation of the PI3K/mTOR Pathway following PARP Inhibition in Small Cell Lung Cancer.
    PLoS One. 2016;11:e0152584.
    PubMed     Text format     Abstract available


  263. PARK SA, Lee JW, Herbst RS, Koo JS, et al
    GSK-3alpha Is a Novel Target of CREB and CREB-GSK-3alpha Signaling Participates in Cell Viability in Lung Cancer.
    PLoS One. 2016;11:e0153075.
    PubMed     Text format     Abstract available


  264. RAES F, Sobilo J, Le Mee M, Retif S, et al
    High Resolution Ultrasound and Photoacoustic Imaging of Orthotopic Lung Cancer in Mice: New Perspectives for Onco-Pharmacology.
    PLoS One. 2016;11:e0153532.
    PubMed     Text format     Abstract available


  265. MIYAZAKI R, Anayama T, Hirohashi K, Okada H, et al
    In Vitro Drug Sensitivity Tests to Predict Molecular Target Drug Responses in Surgically Resected Lung Cancer.
    PLoS One. 2016;11:e0152665.
    PubMed     Text format     Abstract available


  266. ZHU W, Zhou K, Zha Y, Chen D, et al
    Diagnostic Value of Serum miR-182, miR-183, miR-210, and miR-126 Levels in Patients with Early-Stage Non-Small Cell Lung Cancer.
    PLoS One. 2016;11:e0153046.
    PubMed     Text format     Abstract available


  267. O SANTOS A, Parrini MC, Camonis J
    RalGPS2 Is Essential for Survival and Cell Cycle Progression of Lung Cancer Cells Independently of Its Established Substrates Ral GTPases.
    PLoS One. 2016;11:e0154840.
    PubMed     Text format     Abstract available


  268. KERNER GS, Koole MJ, Bongaerts AH, Pruim J, et al
    Total Body Metabolic Tumor Response in ALK Positive Non-Small Cell Lung Cancer Patients Treated with ALK Inhibition.
    PLoS One. 2016;11:e0149955.
    PubMed     Text format     Abstract available


  269. SUTIMAN N, Zhang Z, Tan EH, Ang MK, et al
    Phase I Study of Oral Vinorelbine in Combination with Erlotinib in Advanced Non-Small Cell Lung Cancer (NSCLC) Using Two Different Schedules.
    PLoS One. 2016;11:e0154316.
    PubMed     Text format     Abstract available


  270. TSENG CY, Lin CH, Wu LY, Wang JS, et al
    Potential Combinational Anti-Cancer Therapy in Non-Small Cell Lung Cancer with Traditional Chinese Medicine Sun-Bai-Pi Extract and Cisplatin.
    PLoS One. 2016;11:e0155469.
    PubMed     Text format     Abstract available


  271. JIN KN, Sung YW, Oh SJ, Choi YR, et al
    Association between Image Characteristics on Chest CT and Severe Pleural Adhesion during Lung Cancer Surgery.
    PLoS One. 2016;11:e0154694.
    PubMed     Text format     Abstract available


  272. GAO C, Shen Y, Jin F, Miao Y, et al
    Cancer Stem Cells in Small Cell Lung Cancer Cell Line H446: Higher Dependency on Oxidative Phosphorylation and Mitochondrial Substrate-Level Phosphorylation than Non-Stem Cancer Cells.
    PLoS One. 2016;11:e0154576.
    PubMed     Text format     Abstract available


  273. CARDONA AF, Rojas L, Wills B, Arrieta O, et al
    Pemetrexed/Carboplatin/Bevacizumab followed by Maintenance Pemetrexed/Bevacizumab in Hispanic Patients with Non-Squamous Non-Small Cell Lung Cancer: Outcomes according to Thymidylate Synthase Expression.
    PLoS One. 2016;11:e0154293.
    PubMed     Text format     Abstract available


  274. BODNAR M, Guerrero P, Perez-Carrasco R, Piotrowska MJ, et al
    Deterministic and Stochastic Study for a Microscopic Angiogenesis Model: Applications to the Lewis Lung Carcinoma.
    PLoS One. 2016;11:e0155553.
    PubMed     Text format     Abstract available


  275. LIU XQ, Kiefl R, Roskopf C, Tian F, et al
    Interactions among Lung Cancer Cells, Fibroblasts, and Macrophages in 3D Co-Cultures and the Impact on MMP-1 and VEGF Expression.
    PLoS One. 2016;11:e0156268.
    PubMed     Text format     Abstract available


  276. ZHU L, Zhang S, Xu X, Wang B, et al
    Increased Biological Effective Dose of Radiation Correlates with Prolonged Survival of Patients with Limited-Stage Small Cell Lung Cancer: A Systematic Review.
    PLoS One. 2016;11:e0156494.
    PubMed     Text format     Abstract available


  277. SALTYBAEVA N, Martini K, Frauenfelder T, Alkadhi H, et al
    Organ Dose and Attributable Cancer Risk in Lung Cancer Screening with Low-Dose Computed Tomography.
    PLoS One. 2016;11:e0155722.
    PubMed     Text format     Abstract available


  278. PATEL YM, Park SL, Carmella SG, Paiano V, et al
    Metabolites of the Polycyclic Aromatic Hydrocarbon Phenanthrene in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer.
    PLoS One. 2016;11:e0156203.
    PubMed     Text format     Abstract available


  279. ZHAO J, Xia Y, Kaminski J, Hao Z, et al
    Treatment-Related Death during Concurrent Chemoradiotherapy for Locally Advanced Non-Small Cell Lung Cancer: A Meta-Analysis of Randomized Studies.
    PLoS One. 2016;11:e0157455.
    PubMed     Text format     Abstract available


  280. ENEWOLD L, Thomas A
    Real-World Patterns of EGFR Testing and Treatment with Erlotinib for Non-Small Cell Lung Cancer in the United States.
    PLoS One. 2016;11:e0156728.
    PubMed     Text format     Abstract available


  281. WEI Y, Zhao W, Huang Y, Yu Q, et al
    A Comparative Study of Noninvasive Hypoxia Imaging with 18F-Fluoroerythronitroimidazole and 18F-Fluoromisonidazole PET/CT in Patients with Lung Cancer.
    PLoS One. 2016;11:e0157606.
    PubMed     Text format     Abstract available


  282. DONG X, Sun X, Sun L, Maxim PG, et al
    Early Change in Metabolic Tumor Heterogeneity during Chemoradiotherapy and Its Prognostic Value for Patients with Locally Advanced Non-Small Cell Lung Cancer.
    PLoS One. 2016;11:e0157836.
    PubMed     Text format     Abstract available


  283. GROTTKE A, Ewald F, Lange T, Norz D, et al
    Downregulation of AKT3 Increases Migration and Metastasis in Triple Negative Breast Cancer Cells by Upregulating S100A4.
    PLoS One. 2016;11:e0146370.
    PubMed     Text format     Abstract available


  284. HUANG Q, Wei H, Wu Z, Li L, et al
    Preferentially Expressed Antigen of Melanoma Prevents Lung Cancer Metastasis.
    PLoS One. 2016;11:e0149640.
    PubMed     Text format     Abstract available


  285. LU YC, Lee YR, Liao JD, Lin CY, et al
    Reversine Induced Multinucleated Cells, Cell Apoptosis and Autophagy in Human Non-Small Cell Lung Cancer Cells.
    PLoS One. 2016;11:e0158587.
    PubMed     Text format     Abstract available


  286. HUNG MS, Chen IC, Lung JH, Lin PY, et al
    Epidermal Growth Factor Receptor Mutation Enhances Expression of Cadherin-5 in Lung Cancer Cells.
    PLoS One. 2016;11:e0158395.
    PubMed     Text format     Abstract available


  287. LI D, Shi J, Du Y, Chen K, et al
    Profiling Analysis of Histone Modifications and Gene Expression in Lewis Lung Carcinoma Murine Cells Resistant to Anti-VEGF Treatment.
    PLoS One. 2016;11:e0158214.
    PubMed     Text format     Abstract available


  288. RAO Q, You A, Guo Z, Zuo B, et al
    Intrahepatic Tissue Implantation Represents a Favorable Approach for Establishing Orthotopic Transplantation Hepatocellular Carcinoma Mouse Models.
    PLoS One. 2016;11:e0148263.
    PubMed     Text format     Abstract available


  289. ANDO K, Okada Y, Akiba M, Kondo T, et al
    Lung Transplantation for Lymphangioleiomyomatosis in Japan.
    PLoS One. 2016;11:e0146749.
    PubMed     Text format     Abstract available


  290. KOO HJ, Lee M, Kim J, Woo CW, et al
    Synergistic Effect of Anti-Angiogenic and Radiation Therapy: Quantitative Evaluation with Dynamic Contrast Enhanced MR Imaging.
    PLoS One. 2016;11:e0148784.
    PubMed     Text format     Abstract available


  291. KIM H, Park CM, Song YS, Sunwoo L, et al
    Measurement Variability of Persistent Pulmonary Subsolid Nodules on Same-Day Repeat CT: What Is the Threshold to Determine True Nodule Growth during Follow-Up?
    PLoS One. 2016;11:e0148853.
    PubMed     Text format     Abstract available


  292. KICIELINSKA J, Szczygiel A, Rossowska J, Anger N, et al
    Oral Administration of Polymyxin B Modulates the Activity of Lipooligosaccharide E. coli B against Lung Metastases in Murine Tumor Models.
    PLoS One. 2016;11:e0148156.
    PubMed     Text format     Abstract available


  293. PAPADODIMA O, Moulos P, Koryllou A, Piroti G, et al
    Modulation of Pathways Underlying Distinct Cell Death Mechanisms in Two Human Lung Cancer Cell Lines in Response to SN1 Methylating Agents Treatment.
    PLoS One. 2016;11:e0160248.
    PubMed     Text format    


  294. IM JS, Herrmann AC, Bernatchez C, Haymaker C, et al
    Immune-Modulation by Epidermal Growth Factor Receptor Inhibitors: Implication on Anti-Tumor Immunity in Lung Cancer.
    PLoS One. 2016;11:e0160004.
    PubMed     Text format     Abstract available


  295. SARDARO A, Saito K, Nakayama E, Valmori D, et al
    Correction: Immune Responses to the Cancer Testis Antigen XAGE-1b in Non Small Cell Lung Cancer Caucasian Patients.
    PLoS One. 2016;11:e0160538.
    PubMed     Text format     Abstract available


  296. LIU M, Feng LX, Sun P, Liu W, et al
    A Novel Bufalin Derivative Exhibited Stronger Apoptosis-Inducing Effect than Bufalin in A549 Lung Cancer Cells and Lower Acute Toxicity in Mice.
    PLoS One. 2016;11:e0159789.
    PubMed     Text format     Abstract available



  297. Retraction: Association of CYP2A6*4 with Susceptibility of Lung Cancer: A Meta-Analysis.
    PLoS One. 2016;11:e0160299.
    PubMed     Text format    


  298. WANG CM, Ling ZG, Wu YB, Cai SQ, et al
    Prognostic Value of Pleural Lavage Cytology in Patients with Lung Cancer Resection: An Updated Meta-Analysis.
    PLoS One. 2016;11:e0157518.
    PubMed     Text format     Abstract available


  299. JIAN ZH, Huang JY, Lin FC, Nfor ON, et al
    Post-Inhaled Corticosteroid Pulmonary Tuberculosis Increases Lung Cancer in Patients with Asthma.
    PLoS One. 2016;11:e0159683.
    PubMed     Text format     Abstract available


  300. LI P, Zhang G, Li J, Yang R, et al
    Long Noncoding RNA RGMB-AS1 Indicates a Poor Prognosis and Modulates Cell Proliferation, Migration and Invasion in Lung Adenocarcinoma.
    PLoS One. 2016;11:e0150790.
    PubMed     Text format     Abstract available


  301. LI W, Pi X, Qiao P, Liu H, et al
    Collecting Protein Biomarkers in Breath Using Electret Filters: A Preliminary Method on New Technical Model and Human Study.
    PLoS One. 2016;11:e0150481.
    PubMed     Text format     Abstract available


  302. CADIER B, Durand-Zaleski I, Thomas D, Chevreul K, et al
    Cost Effectiveness of Free Access to Smoking Cessation Treatment in France Considering the Economic Burden of Smoking-Related Diseases.
    PLoS One. 2016;11:e0148750.
    PubMed     Text format     Abstract available


  303. ROONEY C, Geh C, Williams V, Heuckmann JM, et al
    Characterization of FGFR1 Locus in sqNSCLC Reveals a Broad and Heterogeneous Amplicon.
    PLoS One. 2016;11:e0149628.
    PubMed     Text format     Abstract available


  304. HUANG T, Li J, Zhang C, Hong Q, et al
    Distinguishing Lung Adenocarcinoma from Lung Squamous Cell Carcinoma by Two Hypomethylated and Three Hypermethylated Genes: A Meta-Analysis.
    PLoS One. 2016;11:e0149088.
    PubMed     Text format     Abstract available


  305. YUAN P, Cao JL, Abuduwufuer A, Wang LM, et al
    Clinical Characteristics and Prognostic Significance of TERT Promoter Mutations in Cancer: A Cohort Study and a Meta-Analysis.
    PLoS One. 2016;11:e0146803.
    PubMed     Text format     Abstract available


  306. LIM EA, Lee H, Bae E, Lim J, et al
    Economic Evaluation of Companion Diagnostic Testing for EGFR Mutations and First-Line Targeted Therapy in Advanced Non-Small Cell Lung Cancer Patients in South Korea.
    PLoS One. 2016;11:e0160155.
    PubMed     Text format     Abstract available


  307. HU X, Pu K, Feng X, Wen S, et al
    Role of Gemcitabine and Pemetrexed as Maintenance Therapy in Advanced NSCLC: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    PLoS One. 2016;11:e0149247.
    PubMed     Text format     Abstract available


  308. WENG TY, Wang CY, Hung YH, Chen WC, et al
    Differential Expression Pattern of THBS1 and THBS2 in Lung Cancer: Clinical Outcome and a Systematic-Analysis of Microarray Databases.
    PLoS One. 2016;11:e0161007.
    PubMed     Text format     Abstract available


  309. KUMAR A, Corey C, Scott I, Shiva S, et al
    Minnelide/Triptolide Impairs Mitochondrial Function by Regulating SIRT3 in P53-Dependent Manner in Non-Small Cell Lung Cancer.
    PLoS One. 2016;11:e0160783.
    PubMed     Text format     Abstract available


  310. LI K, Yu Y, Sun S, Liu Y, et al
    Functional Characterisation of Anticancer Activity in the Aqueous Extract of Helicteres angustifolia L. Roots.
    PLoS One. 2016;11:e0152017.
    PubMed     Text format     Abstract available


  311. FURUYA M, Tanaka R, Okudela K, Nakamura S, et al
    Pulmonary Neoplasms in Patients with Birt-Hogg-Dube Syndrome: Histopathological Features and Genetic and Somatic Events.
    PLoS One. 2016;11:e0151476.
    PubMed     Text format     Abstract available


  312. SHENG J, Yang YP, Ma YX, Qin T, et al
    Low Prognostic Nutritional Index Correlates with Worse Survival in Patients with Advanced NSCLC following EGFR-TKIs.
    PLoS One. 2016;11:e0147226.
    PubMed     Text format     Abstract available


  313. LI BT, Lou E, Hsu M, Yu HA, et al
    Serum Biomarkers Associated with Clinical Outcomes Fail to Predict Brain Metastases in Patients with Stage IV Non-Small Cell Lung Cancers.
    PLoS One. 2016;11:e0146063.
    PubMed     Text format     Abstract available


  314. DIETZ S, Schirmer U, Merce C, von Bubnoff N, et al
    Low Input Whole-Exome Sequencing to Determine the Representation of the Tumor Exome in Circulating DNA of Non-Small Cell Lung Cancer Patients.
    PLoS One. 2016;11:e0161012.
    PubMed     Text format     Abstract available


  315. ZHANG W, Ning N, Li X, Niu G, et al
    Changes of Brain Glucose Metabolism in the Pretreatment Patients with Non-Small Cell Lung Cancer: A Retrospective PET/CT Study.
    PLoS One. 2016;11:e0161325.
    PubMed     Text format     Abstract available


  316. BEN AMOR A, Beauchemin K, Faucher MC, Hamzaoui A, et al
    Human Leukocyte Antigen G Polymorphism and Expression Are Associated with an Increased Risk of Non-Small-Cell Lung Cancer and Advanced Disease Stage.
    PLoS One. 2016;11:e0161210.
    PubMed     Text format     Abstract available


  317. REIGSTAD I, Smeland HY, Skogstrand T, Sortland K, et al
    Stromal Integrin alpha11beta1 Affects RM11 Prostate and 4T1 Breast Xenograft Tumors Differently.
    PLoS One. 2016;11:e0151663.
    PubMed     Text format     Abstract available


  318. ARENS AI, Postema JW, Schreurs WM, Lafeber A, et al
    FDG-PET/CT Limited to the Thorax and Upper Abdomen for Staging and Management of Lung Cancer.
    PLoS One. 2016;11:e0160539.
    PubMed     Text format     Abstract available


  319. O'DOWD EL, McKeever TM, Baldwin DR, Hubbard RB, et al
    Place of Death in Patients with Lung Cancer: A Retrospective Cohort Study from 2004-2013.
    PLoS One. 2016;11:e0161399.
    PubMed     Text format     Abstract available


  320. KIM EY, Kim YS, Seo JY, Park I, et al
    The Relationship between Sarcopenia and Systemic Inflammatory Response for Cancer Cachexia in Small Cell Lung Cancer.
    PLoS One. 2016;11:e0161125.
    PubMed     Text format     Abstract available


  321. SALAMEKH S, Rong Y, Ayan AS, Mo X, et al
    Inter-Fraction Tumor Volume Response during Lung Stereotactic Body Radiation Therapy Correlated to Patient Variables.
    PLoS One. 2016;11:e0153245.
    PubMed     Text format     Abstract available


  322. KIKUTAKE C, Yahara K
    Identification of Epigenetic Biomarkers of Lung Adenocarcinoma through Multi-Omics Data Analysis.
    PLoS One. 2016;11:e0152918.
    PubMed     Text format     Abstract available


  323. GHAGHADA KB, Sato AF, Starosolski ZA, Berg J, et al
    Computed Tomography Imaging of Solid Tumors Using a Liposomal-Iodine Contrast Agent in Companion Dogs with Naturally Occurring Cancer.
    PLoS One. 2016;11:e0152718.
    PubMed     Text format     Abstract available


  324. PATEL P, Kato T, Ujiie H, Wada H, et al
    Multi-Modal Imaging in a Mouse Model of Orthotopic Lung Cancer.
    PLoS One. 2016;11:e0161991.
    PubMed     Text format     Abstract available


  325. HU X, He W, Wen S, Feng X, et al
    Is IMRT Superior or Inferior to 3DCRT in Radiotherapy for NSCLC? A Meta-Analysis.
    PLoS One. 2016;11:e0151988.
    PubMed     Text format     Abstract available


  326. CASTRO NP, Merchant AS, Saylor KL, Anver MR, et al
    Adaptation of Laser Microdissection Technique for the Study of a Spontaneous Metastatic Mammary Carcinoma Mouse Model by NanoString Technologies.
    PLoS One. 2016;11:e0153270.
    PubMed     Text format     Abstract available


  327. LIEW KL, Jee JM, Yap I, Yong PV, et al
    In Vitro Analysis of Metabolites Secreted during Infection of Lung Epithelial Cells by Cryptococcus neoformans.
    PLoS One. 2016;11:e0153356.
    PubMed     Text format     Abstract available


  328. SABER A, van der Wekken AJ, Kok K, Terpstra MM, et al
    Genomic Aberrations in Crizotinib Resistant Lung Adenocarcinoma Samples Identified by Transcriptome Sequencing.
    PLoS One. 2016;11:e0153065.
    PubMed     Text format     Abstract available


  329. KASAI S, Arakawa N, Okubo A, Shigeeda W, et al
    NAD(P)H:Quinone Oxidoreductase-1 Expression Sensitizes Malignant Melanoma Cells to the HSP90 Inhibitor 17-AAG.
    PLoS One. 2016;11:e0153181.
    PubMed     Text format     Abstract available


  330. GRECKA E, Statkiewicz M, Gorska A, Biernacka M, et al
    Prenyl Ammonium Salts - New Carriers for Gene Delivery: A B16-F10 Mouse Melanoma Model.
    PLoS One. 2016;11:e0153633.
    PubMed     Text format     Abstract available


  331. SEHGAL IS, Dhooria S, Gupta N, Bal A, et al
    Impact of Endobronchial Ultrasound (EBUS) Training on the Diagnostic Yield of Conventional Transbronchial Needle Aspiration for Lymph Node Stations 4R and 7.
    PLoS One. 2016;11:e0153793.
    PubMed     Text format     Abstract available


  332. NORONHA V, Ramaswamy A, Patil VM, Joshi A, et al
    ALK Positive Lung Cancer: Clinical Profile, Practice and Outcomes in a Developing Country.
    PLoS One. 2016;11:e0160752.
    PubMed     Text format     Abstract available


  333. FENG Y, Zhou J, Li Z, Jiang Y, et al
    Small Molecular TRAIL Inducer ONC201 Induces Death in Lung Cancer Cells: A Preclinical Study.
    PLoS One. 2016;11:e0162133.
    PubMed     Text format     Abstract available


  334. KOO HJ, Do KH, Lee JB, Alblushi S, et al
    Lung Cancer in Combined Pulmonary Fibrosis and Emphysema: A Systematic Review and Meta-Analysis.
    PLoS One. 2016;11:e0161437.
    PubMed     Text format     Abstract available


  335. ZENG Y, Ruan W, He J, Zhang J, et al
    Adoptive Immunotherapy in Postoperative Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis.
    PLoS One. 2016;11:e0162630.
    PubMed     Text format     Abstract available


  336. FLECKENSTEIN J, Jelden M, Kremp S, Jagoda P, et al
    The Impact of Diffusion-Weighted MRI on the Definition of Gross Tumor Volume in Radiotherapy of Non-Small-Cell Lung Cancer.
    PLoS One. 2016;11:e0162816.
    PubMed     Text format     Abstract available


  337. LEE H, Kim Y, Jeong JH, Ryu JH, et al
    ATM/CHK/p53 Pathway Dependent Chemopreventive and Therapeutic Activity on Lung Cancer by Pterostilbene.
    PLoS One. 2016;11:e0162335.
    PubMed     Text format     Abstract available


  338. CHI A, Wen S, Monga M, Almubarak M, et al
    Definitive Upfront Stereotactic Ablative Radiotherapy Combined with Image-Guided, Intensity Modulated Radiotherapy (IG-IMRT) or IG-IMRT Alone for Locally Advanced Non-Small Cell Lung Cancer.
    PLoS One. 2016;11:e0162453.
    PubMed     Text format     Abstract available


  339. YAN F, Pang J, Peng Y, Molina JR, et al
    Elevated Cellular PD1/PD-L1 Expression Confers Acquired Resistance to Cisplatin in Small Cell Lung Cancer Cells.
    PLoS One. 2016;11:e0162925.
    PubMed     Text format     Abstract available


  340. TRAN TB, Baek C, Min J
    Electric Cell-Substrate Impedance Sensing (ECIS) with Microelectrode Arrays for Investigation of Cancer Cell-Fibroblasts Interaction.
    PLoS One. 2016;11:e0153813.
    PubMed     Text format     Abstract available


  341. KANG HJ, Hwangbo B, Lee JS, Kim MS, et al
    Comparison of Epidermal Growth Factor Receptor Mutations between Metastatic Lymph Node Diagnosed by EBUS-TBNA and Primary Tumor in Non-Small Cell Lung Cancer.
    PLoS One. 2016;11:e0163652.
    PubMed     Text format     Abstract available


  342. LI H, Ren Y, Xia L, Qu R, et al
    Association of MicroRNA-149 Polymorphism with Lung Cancer Risk in Chinese Non-Smoking Female: A Case-Control Study.
    PLoS One. 2016;11:e0163626.
    PubMed     Text format     Abstract available


  343. KIM EY, Kim N, Kim YS, Seo JY, et al
    Prognostic Significance of Modified Advanced Lung Cancer Inflammation Index (ALI) in Patients with Small Cell Lung Cancer_ Comparison with Original ALI.
    PLoS One. 2016;11:e0164056.
    PubMed     Text format     Abstract available


  344. WANG J, Kalhor N, Hu J, Wang B, et al
    Pretreatment Neutrophil to Lymphocyte Ratio Is Associated with Poor Survival in Patients with Stage I-III Non-Small Cell Lung Cancer.
    PLoS One. 2016;11:e0163397.
    PubMed     Text format     Abstract available


  345. FUJITA H, Gomori A, Fujioka Y, Kataoka Y, et al
    High Potency VEGFRs/MET/FMS Triple Blockade by TAS-115 Concomitantly Suppresses Tumor Progression and Bone Destruction in Tumor-Induced Bone Disease Model with Lung Carcinoma Cells.
    PLoS One. 2016;11:e0164830.
    PubMed     Text format     Abstract available


  346. WANG Z, Hu Y, Wang Y, Han W, et al
    Can CT Screening Give Rise to a Beneficial Stage Shift in Lung Cancer Patients? Systematic Review and Meta-Analysis.
    PLoS One. 2016;11:e0164416.
    PubMed     Text format     Abstract available


  347. LYCAN TW, Pardee TS, Petty WJ, Bonomi M, et al
    A Phase II Clinical Trial of CPI-613 in Patients with Relapsed or Refractory Small Cell Lung Carcinoma.
    PLoS One. 2016;11:e0164244.
    PubMed     Text format     Abstract available


  348. LIN J, Zhang Y, Wang H, Chang J, et al
    Genetic Polymorphisms in the Apoptosis-Associated Gene CASP3 and the Risk of Lung Cancer in Chinese Population.
    PLoS One. 2016;11:e0164358.
    PubMed     Text format     Abstract available


  349. ZAPOROZHCHENKO IA, Morozkin ES, Skvortsova TE, Ponomaryova AA, et al
    Plasma miR-19b and miR-183 as Potential Biomarkers of Lung Cancer.
    PLoS One. 2016;11:e0165261.
    PubMed     Text format     Abstract available


  350. KORRODI-GREGORIO L, Soto-Cerrato V, Vitorino R, Fardilha M, et al
    From Proteomic Analysis to Potential Therapeutic Targets: Functional Profile of Two Lung Cancer Cell Lines, A549 and SW900, Widely Studied in Pre-Clinical Research.
    PLoS One. 2016;11:e0165973.
    PubMed     Text format     Abstract available


  351. WAGLAND R, Brindle L, Ewings S, James E, et al
    Promoting Help-Seeking in Response to Symptoms amongst Primary Care Patients at High Risk of Lung Cancer: A Mixed Method Study.
    PLoS One. 2016;11:e0165677.
    PubMed     Text format     Abstract available


  352. KINSEY CM, Hamlington KL, O'Toole J, Stapleton R, et al
    Predicting the Mortality Benefit of CT Screening for Second Lung Cancer in a High-Risk Population.
    PLoS One. 2016;11:e0165471.
    PubMed     Text format     Abstract available


  353. WALTER RF, Werner R, Vollbrecht C, Hager T, et al
    ACTB, CDKN1B, GAPDH, GRB2, RHOA and SDCBP Were Identified as Reference Genes in Neuroendocrine Lung Cancer via the nCounter Technology.
    PLoS One. 2016;11:e0165181.
    PubMed     Text format     Abstract available


  354. KRUER TL, Dougherty SM, Reynolds L, Long E, et al
    Expression of the lncRNA Maternally Expressed Gene 3 (MEG3) Contributes to the Control of Lung Cancer Cell Proliferation by the Rb Pathway.
    PLoS One. 2016;11:e0166363.
    PubMed     Text format     Abstract available


  355. KUNISAWA S, Fushimi K, Imanaka Y
    Reducing Length of Hospital Stay Does Not Increase Readmission Rates in Early-Stage Gastric, Colon, and Lung Cancer Surgical Cases in Japanese Acute Care Hospitals.
    PLoS One. 2016;11:e0166269.
    PubMed     Text format     Abstract available


  356. MIYAZAKI R, Anayama T, Hirohashi K, Okada H, et al
    Correction: In Vitro Drug Sensitivity Tests to Predict Molecular Target Drug Responses in Surgically Resected Lung Cancer.
    PLoS One. 2016;11:e0166505.
    PubMed     Text format     Abstract available


  357. WANG BY, Huang JY, Hung WH, Lin CH, et al
    Impact on Survival on Interval between Surgery and Adjuvant Chemotherapy in Completely Resected Stage IB-IIIA Lung Cancer.
    PLoS One. 2016;11:e0163809.
    PubMed     Text format     Abstract available


  358. MENG Q, Ren M, Li Y, Song X, et al
    LncRNA-RMRP Acts as an Oncogene in Lung Cancer.
    PLoS One. 2016;11:e0164845.
    PubMed     Text format     Abstract available



  359. Correction: ALK Positive Lung Cancer: Clinical Profile, Practice and Outcomes in a Developing Country.
    PLoS One. 2016;11:e0168221.
    PubMed     Text format     Abstract available


  360. CHEN YM, Fang YT, Lai CH, Rau KM, et al
    A Survival Scoring System for Non-Small Cell Lung Cancer Patients with De Novo Bone Metastases.
    PLoS One. 2016;11:e0167923.
    PubMed     Text format     Abstract available


  361. HELLWIG B, Madjar K, Edlund K, Marchan R, et al
    Epsin Family Member 3 and Ribosome-Related Genes Are Associated with Late Metastasis in Estrogen Receptor-Positive Breast Cancer and Long-Term Survival in Non-Small Cell Lung Cancer Using a Genome-Wide Identification and Validation Strategy.
    PLoS One. 2016;11:e0167585.
    PubMed     Text format     Abstract available


  362. PRICE DN, McBride AA, Anton M, Kusewitt DF, et al
    Longitudinal Assessment of Lung Cancer Progression in Mice Using the Sodium Iodide Symporter Reporter Gene and SPECT/CT Imaging.
    PLoS One. 2016;11:e0169107.
    PubMed     Text format     Abstract available


  363. SUN L, Liu X, Fu H, Zhou W, et al
    2-Deoxyglucose Suppresses ERK Phosphorylation in LKB1 and Ras Wild-Type Non-Small Cell Lung Cancer Cells.
    PLoS One. 2016;11:e0168793.
    PubMed     Text format     Abstract available


  364. FUJIMOTO D, Kato R, Morimoto T, Shimizu R, et al
    Characteristics and Prognostic Impact of Pneumonitis during Systemic Anti-Cancer Therapy in Patients with Advanced Non-Small-Cell Lung Cancer.
    PLoS One. 2016;11:e0168465.
    PubMed     Text format     Abstract available


  365. LAI X, Friedman A
    Exosomal miRs in Lung Cancer: A Mathematical Model.
    PLoS One. 2016;11:e0167706.
    PubMed     Text format     Abstract available


  366. WEI WE, Mao NQ, Ning SF, Li JL, et al
    An Analysis of EGFR Mutations among 1506 Cases of Non-Small Cell Lung Cancer Patients in Guangxi, China.
    PLoS One. 2016;11:e0168795.
    PubMed     Text format     Abstract available


  367. AMERATUNGA M, Asadi K, Lin X, Walkiewicz M, et al
    PD-L1 and Tumor Infiltrating Lymphocytes as Prognostic Markers in Resected NSCLC.
    PLoS One. 2016;11:e0153954.
    PubMed     Text format     Abstract available


  368. GOK DURNALI A, Paksoy Turkoz F, Ardic Yukruk F, Tokluoglu S, et al
    Outcomes of Adolescent and Adult Patients with Lung Metastatic Osteosarcoma and Comparison of Synchronous and Metachronous Lung Metastatic Groups.
    PLoS One. 2016;11:e0152621.
    PubMed     Text format     Abstract available


  369. ZHANG L, Qian H, Sha M, Luan Z, et al
    Downregulation of HOTAIR Expression Mediated Anti-Metastatic Effect of Artesunate on Cervical Cancer by Inhibiting COX-2 Expression.
    PLoS One. 2016;11:e0164838.
    PubMed     Text format     Abstract available


  370. FORGACS A, Pall Jonsson H, Dahlbom M, Daver F, et al
    A Study on the Basic Criteria for Selecting Heterogeneity Parameters of F18-FDG PET Images.
    PLoS One. 2016;11:e0164113.
    PubMed     Text format     Abstract available


  371. ZHANG L, Wang L, Tian P, Tian S, et al
    Identification of Genes Discriminating Multiple Sclerosis Patients from Controls by Adapting a Pathway Analysis Method.
    PLoS One. 2016;11:e0165543.
    PubMed     Text format     Abstract available


  372. APRELIKOVA O, Tomlinson CC, Hoenerhoff M, Hixon JA, et al
    Development and Preclinical Application of an Immunocompetent Transplant Model of Basal Breast Cancer with Lung, Liver and Brain Metastases.
    PLoS One. 2016;11:e0155262.
    PubMed     Text format     Abstract available


  373. SCHUSTER C, Akslen LA, Straume O
    Expression of Heat Shock Protein 27 in Melanoma Metastases Is Associated with Overall Response to Bevacizumab Monotherapy: Analyses of Predictive Markers in a Clinical Phase II Study.
    PLoS One. 2016;11:e0155242.
    PubMed     Text format     Abstract available


  374. SLADE RL, Pisaneschi F, Nguyen QD, Smith G, et al
    Identification of ABC Transporter Interaction of a Novel Cyanoquinoline Radiotracer and Implications for Tumour Imaging by Positron Emission Tomography.
    PLoS One. 2016;11:e0161427.
    PubMed     Text format     Abstract available


  375. WANG D, Zhang M, Gao X, Yu L, et al
    Prognostic Value of Baseline 18F-FDG PET/CT Functional Parameters in Patients with Advanced Lung Adenocarcinoma Stratified by EGFR Mutation Status.
    PLoS One. 2016;11:e0158307.
    PubMed     Text format     Abstract available


    January 2015
  376. MORENO P, Lara-Chica M, Soler-Torronteras R, Caro T, et al
    The Expression of the Ubiquitin Ligase SIAH2 (Seven In Absentia Homolog 2) Is Increased in Human Lung Cancer.
    PLoS One. 2015;10:e0143376.
    PubMed     Text format     Abstract available


  377. GOZZARD P, Chapman C, Vincent A, Lang B, et al
    Novel Humoral Prognostic Markers in Small-Cell Lung Carcinoma: A Prospective Study.
    PLoS One. 2015;10:e0143558.
    PubMed     Text format     Abstract available


  378. HU X, Zhang L, Shi Y, Zhou C, et al
    The Efficacy and Safety of Icotinib in Patients with Advanced Non-Small Cell Lung Cancer Previously Treated with Chemotherapy: A Single-Arm, Multi-Center, Prospective Study.
    PLoS One. 2015;10:e0142500.
    PubMed     Text format     Abstract available


  379. SHI Y, Li J, Zhang S, Wang M, et al
    Molecular Epidemiology of EGFR Mutations in Asian Patients with Advanced Non-Small-Cell Lung Cancer of Adenocarcinoma Histology - Mainland China Subset Analysis of the PIONEER study.
    PLoS One. 2015;10:e0143515.
    PubMed     Text format     Abstract available


  380. WEN SW, Everitt SJ, Bedo J, Chabrot M, et al
    Spleen Volume Variation in Patients with Locally Advanced Non-Small Cell Lung Cancer Receiving Platinum-Based Chemo-Radiotherapy.
    PLoS One. 2015;10:e0142608.
    PubMed     Text format     Abstract available


  381. ZHAN W, Han T, Zhang C, Xie C, et al
    TRIM59 Promotes the Proliferation and Migration of Non-Small Cell Lung Cancer Cells by Upregulating Cell Cycle Related Proteins.
    PLoS One. 2015;10:e0142596.
    PubMed     Text format     Abstract available


  382. MING X, Feng Y, Liu H, Zhang Y, et al
    Cardiac Exposure in the Dynamic Conformal Arc Therapy, Intensity-Modulated Radiotherapy and Volumetric Modulated Arc Therapy of Lung Cancer.
    PLoS One. 2015;10:e0144211.
    PubMed     Text format     Abstract available


  383. ADETIBA E, Olugbara OO
    Improved Classification of Lung Cancer Using Radial Basis Function Neural Network with Affine Transforms of Voss Representation.
    PLoS One. 2015;10:e0143542.
    PubMed     Text format     Abstract available


  384. SASI SP, Bae S, Song J, Perepletchikov A, et al
    Correction: Therapeutic Non-Toxic Doses of TNF Induce Significant Regression in TNFR2-p75 Knockdown Lewis Lung Carcinoma Tumor Implants.
    PLoS One. 2015;10:e0144213.
    PubMed     Text format     Abstract available


  385. FISCELLA K, Winters P, Farah S, Sanders M, et al
    Do Lung Cancer Eligibility Criteria Align with Risk among Blacks and Hispanics?
    PLoS One. 2015;10:e0143789.
    PubMed     Text format     Abstract available


  386. JIN Y, Liu Y, Zhang J, Huang W, et al
    The Expression of miR-375 Is Associated with Carcinogenesis in Three Subtypes of Lung Cancer.
    PLoS One. 2015;10:e0144187.
    PubMed     Text format     Abstract available


  387. ZHANG Y, Feng Y, Ahmad M, Ming X, et al
    Intermediate Megavoltage Photon Beams for Improved Lung Cancer Treatments.
    PLoS One. 2015;10:e0145117.
    PubMed     Text format     Abstract available


  388. ORLHAC F, Soussan M, Chouahnia K, Martinod E, et al
    18F-FDG PET-Derived Textural Indices Reflect Tissue-Specific Uptake Pattern in Non-Small Cell Lung Cancer.
    PLoS One. 2015;10:e0145063.
    PubMed     Text format     Abstract available


  389. SUN H, Hu P, Shen H, Dong W, et al
    Albumin and Neutrophil Combined Prognostic Grade as a New Prognostic Factor in Non-Small Cell Lung Cancer: Results from a Large Consecutive Cohort.
    PLoS One. 2015;10:e0144663.
    PubMed     Text format     Abstract available


  390. TSAI JR, Liu PL, Chen YH, Chou SH, et al
    Curcumin Inhibits Non-Small Cell Lung Cancer Cells Metastasis through the Adiponectin/NF-kappab/MMPs Signaling Pathway.
    PLoS One. 2015;10:e0144462.
    PubMed     Text format     Abstract available


  391. KANG JI, Hong JY, Lee HJ, Bae SY, et al
    Anti-Tumor Activity of Yuanhuacine by Regulating AMPK/mTOR Signaling Pathway and Actin Cytoskeleton Organization in Non-Small Cell Lung Cancer Cells.
    PLoS One. 2015;10:e0144368.
    PubMed     Text format     Abstract available


  392. DELAHAYE-SOURDEIX M, Oliver J, Timofeeva MN, Gaborieau V, et al
    The 12p13.33/RAD52 locus and genetic susceptibility to squamous cell cancers of upper aerodigestive tract.
    PLoS One. 2015;10:e0117639.
    PubMed     Text format     Abstract available


  393. HSU KH, Ho CC, Hsia TC, Tseng JS, et al
    Identification of five driver gene mutations in patients with treatment-naive lung adenocarcinoma in Taiwan.
    PLoS One. 2015;10:e0120852.
    PubMed     Text format     Abstract available


  394. KOCARNIK JM, Park SL, Han J, Dumitrescu L, et al
    Pleiotropic and Sex-Specific Effects of Cancer GWAS SNPs on Melanoma Risk in the Population Architecture Using Genomics and Epidemiology (PAGE) Study.
    PLoS One. 2015;10:e0120491.
    PubMed     Text format     Abstract available


  395. SILVA IT, Carvalho A, Lang KL, Dudek SE, et al
    In vitro and in vivo antitumor activity of a novel semisynthetic derivative of cucurbitacin B.
    PLoS One. 2015;10:e0117794.
    PubMed     Text format     Abstract available


  396. SRIRAM N, Mills J, Lang E, Dickson HK, et al
    Attitudes and Stereotypes in Lung Cancer versus Breast Cancer.
    PLoS One. 2015;10:e0145715.
    PubMed     Text format     Abstract available


  397. PHILLIPS M, Bauer TL, Cataneo RN, Lebauer C, et al
    Blinded Validation of Breath Biomarkers of Lung Cancer, a Potential Ancillary to Chest CT Screening.
    PLoS One. 2015;10:e0142484.
    PubMed     Text format     Abstract available


  398. HYUN SH, Lee KH, Choi JY, Kim BT, et al
    Influence of Body Mass Index on the Prognostic Value of Tumor (1)(8)F-FDG Uptake in Stage I Non-Small Cell Lung Cancer.
    PLoS One. 2015;10:e0145020.
    PubMed     Text format     Abstract available


  399. MULLAPUDI N, Ye B, Suzuki M, Fazzari M, et al
    Genome Wide Methylome Alterations in Lung Cancer.
    PLoS One. 2015;10:e0143826.
    PubMed     Text format     Abstract available


  400. MORRISON A, Chekaluk Y, Bacares R, Ladanyi M, et al
    BAP1 missense mutation c.2054 A>T (p.E685V) completely disrupts normal splicing through creation of a novel 5' splice site in a human mesothelioma cell line.
    PLoS One. 2015;10:e0119224.
    PubMed     Text format     Abstract available


  401. CHIANG Y, Yang JC, Hsu FM, Chen YH, et al
    The Response, Outcome and Toxicity of Aggressive Palliative Thoracic Radiotherapy for Metastatic Non-Small Cell Lung Cancer Patients with Controlled Extrathoracic Diseases.
    PLoS One. 2015;10:e0145936.
    PubMed     Text format     Abstract available


  402. CHATTOPADHYAY N, Berger AJ, Koenig E, Bannerman B, et al
    KRAS Genotype Correlates with Proteasome Inhibitor Ixazomib Activity in Preclinical In Vivo Models of Colon and Non-Small Cell Lung Cancer: Potential Role of Tumor Metabolism.
    PLoS One. 2015;10:e0144825.
    PubMed     Text format     Abstract available


  403. MCKAY AJ, Patel RK, Majeed A
    Strategies for tobacco control in India: a systematic review.
    PLoS One. 2015;10:e0122610.
    PubMed     Text format     Abstract available


  404. CAO L, Tong H, Xu G, Liu P, et al
    Systemic lupus erythematous and malignancy risk: a meta-analysis.
    PLoS One. 2015;10:e0122964.
    PubMed     Text format     Abstract available


  405. MISHRA EK, Corcoran JP, Hallifax RJ, Stradling J, et al
    Defining the minimal important difference for the visual analogue scale assessing dyspnea in patients with malignant pleural effusions.
    PLoS One. 2015;10:e0123798.
    PubMed     Text format     Abstract available


  406. CHIEN CH, Lee MJ, Liou HC, Liou HH, et al
    Local Immunosuppressive Microenvironment Enhances Migration of Melanoma Cells to Lungs in DJ-1 Knockout Mice.
    PLoS One. 2015;10:e0115827.
    PubMed     Text format     Abstract available


  407. SHAN L, Lian F, Guo L, Qiu T, et al
    Detection of ROS1 gene rearrangement in lung adenocarcinoma: comparison of IHC, FISH and real-time RT-PCR.
    PLoS One. 2015;10:e0120422.
    PubMed     Text format     Abstract available


  408. GROVE O, Berglund AE, Schabath MB, Aerts HJ, et al
    Quantitative computed tomographic descriptors associate tumor shape complexity and intratumor heterogeneity with prognosis in lung adenocarcinoma.
    PLoS One. 2015;10:e0118261.
    PubMed     Text format     Abstract available


  409. HUANG AH, Pan SH, Chang WH, Hong QS, et al
    PARVA promotes metastasis by modulating ILK signalling pathway in lung adenocarcinoma.
    PLoS One. 2015;10:e0118530.
    PubMed     Text format     Abstract available


  410. TSAY JC, Li Z, Yie TA, Wu F, et al
    Molecular characterization of the peripheral airway field of cancerization in lung adenocarcinoma.
    PLoS One. 2015;10:e0118132.
    PubMed     Text format     Abstract available


  411. REDANIEL MT, Martin RM, Ridd MJ, Wade J, et al
    Diagnostic intervals and its association with breast, prostate, lung and colorectal cancer survival in England: historical cohort study using the clinical practice research datalink.
    PLoS One. 2015;10:e0126608.
    PubMed     Text format     Abstract available


  412. PASDAR EA, Smits M, Stapelberg M, Bajzikova M, et al
    Characterisation of mesothelioma-initiating cells and their susceptibility to anti-cancer agents.
    PLoS One. 2015;10:e0119549.
    PubMed     Text format     Abstract available


  413. PENG H, Ma J, Bai Y, Lu J, et al
    MeDiA: Mean Distance Association and Its Applications in Nonlinear Gene Set Analysis.
    PLoS One. 2015;10:e0124620.
    PubMed     Text format     Abstract available


  414. ANOTA A, Mouillet G, Trouilloud I, Dupont-Gossart AC, et al
    Sequential FOLFIRI.3 + Gemcitabine Improves Health-Related Quality of Life Deterioration-Free Survival of Patients with Metastatic Pancreatic Adenocarcinoma: A Randomized Phase II Trial.
    PLoS One. 2015;10:e0125350.
    PubMed     Text format     Abstract available


  415. CHU HL, Yip BS, Chen KH, Yu HY, et al
    Novel antimicrobial peptides with high anticancer activity and selectivity.
    PLoS One. 2015;10:e0126390.
    PubMed     Text format     Abstract available


  416. CAPPELLESSO R, Millioni R, Arrigoni G, Simonato F, et al
    Lumican is overexpressed in lung adenocarcinoma pleural effusions.
    PLoS One. 2015;10:e0126458.
    PubMed     Text format     Abstract available


  417. JAIN A, Lim C, Gan EM, Ng DZ, et al
    Impact of Smoking and Brain Metastasis on Outcomes of Advanced EGFR Mutation Lung Adenocarcinoma Patients Treated with First Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors.
    PLoS One. 2015;10:e0123587.
    PubMed     Text format     Abstract available


  418. KAMOMAE T, Monzen H, Nakayama S, Mizote R, et al
    Accuracy of image guidance using free-breathing cone-beam computed tomography for stereotactic lung radiotherapy.
    PLoS One. 2015;10:e0126152.
    PubMed     Text format     Abstract available


  419. D'ARCANGELO M, Todaro M, Salvini J, Benfante A, et al
    Cancer Stem Cells Sensitivity Assay (STELLA) in Patients with Advanced Lung and Colorectal Cancer: A Feasibility Study.
    PLoS One. 2015;10:e0125037.
    PubMed     Text format     Abstract available


  420. MISIC VV, Chan TC
    The perils of adapting to dose errors in radiation therapy.
    PLoS One. 2015;10:e0125335.
    PubMed     Text format     Abstract available


  421. CUNNIFF B, Newick K, Nelson KJ, Wozniak AN, et al
    Disabling Mitochondrial Peroxide Metabolism via Combinatorial Targeting of Peroxiredoxin 3 as an Effective Therapeutic Approach for Malignant Mesothelioma.
    PLoS One. 2015;10:e0127310.
    PubMed     Text format     Abstract available


  422. PENA N, Carrillo D, Munoz JP, Chnaiderman J, et al
    Tobacco smoke activates human papillomavirus 16 p97 promoter and cooperates with high-risk E6/E7 for oxidative DNA damage in lung cells.
    PLoS One. 2015;10:e0123029.
    PubMed     Text format     Abstract available


  423. HECHT SS, Koh WP, Wang R, Chen M, et al
    Elevated levels of mercapturic acids of acrolein and crotonaldehyde in the urine of Chinese women in Singapore who regularly cook at home.
    PLoS One. 2015;10:e0120023.
    PubMed     Text format     Abstract available


  424. SCHWEIGER T, Nikolowsky C, Starlinger P, Traxler D, et al
    Stromal expression of heat-shock protein 27 is associated with worse clinical outcome in patients with colorectal cancer lung metastases.
    PLoS One. 2015;10:e0120724.
    PubMed     Text format     Abstract available


  425. LIU L, Zhan P, Zhou X, Song Y, et al
    Detection of EML4-ALK in lung adenocarcinoma using pleural effusion with FISH, IHC, and RT-PCR methods.
    PLoS One. 2015;10:e0117032.
    PubMed     Text format     Abstract available


  426. LIU J, Wan L, Lu K, Sun M, et al
    The Long Noncoding RNA MEG3 Contributes to Cisplatin Resistance of Human Lung Adenocarcinoma.
    PLoS One. 2015;10:e0114586.
    PubMed     Text format     Abstract available


  427. LIN H, Kou B, Li X, Wang Y, et al
    Grating-based phase-contrast imaging of tumor angiogenesis in lung metastases.
    PLoS One. 2015;10:e0121438.
    PubMed     Text format     Abstract available


  428. ZANDVAKILI I, Davis AK, Hu G, Zheng Y, et al
    Loss of RhoA Exacerbates, Rather Than Dampens, Oncogenic K-Ras Induced Lung Adenoma Formation in Mice.
    PLoS One. 2015;10:e0127923.
    PubMed     Text format     Abstract available


  429. ZOLLNER S, Sokolnikov ME, Eidemuller M
    Beyond two-stage models for lung carcinogenesis in the Mayak workers: implications for plutonium risk.
    PLoS One. 2015;10:e0126238.
    PubMed     Text format     Abstract available


  430. FIGEAC F, Dagouassat M, Mahrouf-Yorgov M, Le Gouvello S, et al
    Lung fibroblasts share mesenchymal stem cell features which are altered in chronic obstructive pulmonary disease via the overactivation of the Hedgehog signaling pathway.
    PLoS One. 2015;10:e0121579.
    PubMed     Text format     Abstract available


  431. KLAMMER M, Dybowski JN, Hoffmann D, Schaab C, et al
    Pareto Optimization Identifies Diverse Set of Phosphorylation Signatures Predicting Response to Treatment with Dasatinib.
    PLoS One. 2015;10:e0128542.
    PubMed     Text format     Abstract available


  432. PATTERSON SD, Rossi JM, Paweletz KL, Fitzpatrick VD, et al
    Functional EpoR pathway utilization is not detected in primary tumor cells isolated from human breast, non-small cell lung, colorectal, and ovarian tumor tissues.
    PLoS One. 2015;10:e0122149.
    PubMed     Text format     Abstract available


  433. AMARAL FE, Parker D, Randis TM, Kulkarni R, et al
    Rational Manipulation of mRNA Folding Free Energy Allows Rheostat Control of Pneumolysin Production by Streptococcus pneumoniae.
    PLoS One. 2015;10:e0119823.
    PubMed     Text format     Abstract available


  434. DURRANS A, Gao D, Gupta R, Fischer KR, et al
    Identification of Reprogrammed Myeloid Cell Transcriptomes in NSCLC.
    PLoS One. 2015;10:e0129123.
    PubMed     Text format     Abstract available


  435. PETERSON SW, Jurjevic Z, Frisvad JC
    Expanding the species and chemical diversity of Penicillium section Cinnamopurpurea.
    PLoS One. 2015;10:e0121987.
    PubMed     Text format     Abstract available


  436. ZHAO J, Ji G, Qiang Y, Han X, et al
    A New Method of Detecting Pulmonary Nodules with PET/CT Based on an Improved Watershed Algorithm.
    PLoS One. 2015;10:e0123694.
    PubMed     Text format     Abstract available


  437. YANG Y, Zhao Q, Cai Z, Cheng G, et al
    Fas Signaling Promotes Gastric Cancer Metastasis through STAT3-Dependent Upregulation of Fascin.
    PLoS One. 2015;10:e0125132.
    PubMed     Text format     Abstract available


  438. HOOGENDAM JP, Zweemer RP, Verkooijen HM, de Jong PA, et al
    No Value for Routine Chest Radiography in the Work-Up of Early Stage Cervical Cancer Patients.
    PLoS One. 2015;10:e0131899.
    PubMed     Text format     Abstract available


  439. SATO M, Matsubara T, Adachi J, Hashimoto Y, et al
    Differential Proteome Analysis Identifies TGF-beta-Related Pro-Metastatic Proteins in a 4T1 Murine Breast Cancer Model.
    PLoS One. 2015;10:e0126483.
    PubMed     Text format     Abstract available


  440. CARBOGNIN L, Pilotto S, Milella M, Vaccaro V, et al
    Differential Activity of Nivolumab, Pembrolizumab and MPDL3280A according to the Tumor Expression of Programmed Death-Ligand-1 (PD-L1): Sensitivity Analysis of Trials in Melanoma, Lung and Genitourinary Cancers.
    PLoS One. 2015;10:e0130142.
    PubMed     Text format     Abstract available


  441. HUANG JY, Jian ZH, Ndi Nfor O, Jhang KM, et al
    The Impact of Coexisting Asthma, Chronic Obstructive Pulmonary Disease and Tuberculosis on Survival in Patients with Lung Squamous Cell Carcinoma.
    PLoS One. 2015;10:e0133367.
    PubMed     Text format     Abstract available


  442. IWASE S, Kawaguchi T, Tokoro A, Yamada K, et al
    Assessment of Cancer-Related Fatigue, Pain, and Quality of Life in Cancer Patients at Palliative Care Team Referral: A Multicenter Observational Study (JORTC PAL-09).
    PLoS One. 2015;10:e0134022.
    PubMed     Text format     Abstract available


  443. MARKOV OV, Mironova NL, Sennikov SV, Vlassov VV, et al
    Prophylactic Dendritic Cell-Based Vaccines Efficiently Inhibit Metastases in Murine Metastatic Melanoma.
    PLoS One. 2015;10:e0136911.
    PubMed     Text format     Abstract available


  444. MAHESWARAN E, Pedersen CB, Ditzel HJ, Gjerstorff MF, et al
    Lack of ADAM2, CALR3 and SAGE1 Cancer/Testis Antigen Expression in Lung and Breast Cancer.
    PLoS One. 2015;10:e0134967.
    PubMed     Text format     Abstract available


  445. HU K, Tang X, Tang G, Yao S, et al
    18F-FP-PEG2-beta-Glu-RGD2: A Symmetric Integrin alphavbeta3-Targeting Radiotracer for Tumor PET Imaging.
    PLoS One. 2015;10:e0138675.
    PubMed     Text format     Abstract available


  446. CALDERON LE, Liu S, Arnold N, Breakall B, et al
    Bromoenol Lactone Attenuates Nicotine-Induced Breast Cancer Cell Proliferation and Migration.
    PLoS One. 2015;10:e0143277.
    PubMed     Text format     Abstract available


  447. STAVRINOU P, Mavrogiorgou MC, Polyzoidis K, Kreft-Kerekes V, et al
    Expression Profile of Genes Related to Drug Metabolism in Human Brain Tumors.
    PLoS One. 2015;10:e0143285.
    PubMed     Text format     Abstract available


  448. ZHANG L, Wu C, Hoffman RM
    Prostate Cancer Heterogeneous High-Metastatic Multi-Organ-Colonizing Chemo-Resistant Variants Selected by Serial Metastatic Passage in Nude Mice Are Highly Enriched for Multinucleate Giant Cells.
    PLoS One. 2015;10:e0140721.
    PubMed     Text format     Abstract available


  449. MIN K, Ji B, Zhao M, Ji T, et al
    Development of a Radiolabeled Peptide-Based Probe Targeting MT1-MMP for Breast Cancer Detection.
    PLoS One. 2015;10:e0139471.
    PubMed     Text format     Abstract available


    January 2014
  450. ZHOU Y, Rideout WM 3rd, Bressel A, Yalavarthi S, et al
    Spontaneous genomic alterations in a chimeric model of colorectal cancer enable metastasis and guide effective combinatorial therapy.
    PLoS One. 2014;9:e105886.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: